<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:56:13Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9689748" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9689748</identifier>
        <datestamp>2022-11-25</datestamp>
        <setSpec>curroncol</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Curr Oncol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Curr Oncol</journal-id>
              <journal-id journal-id-type="publisher-id">curroncol</journal-id>
              <journal-title-group>
                <journal-title>Current Oncology</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1198-0052</issn>
              <issn pub-type="epub">1718-7729</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9689748</article-id>
              <article-id pub-id-type="pmcid">PMC9689748</article-id>
              <article-id pub-id-type="pmc-uid">9689748</article-id>
              <article-id pub-id-type="pmid">36354718</article-id>
              <article-id pub-id-type="pmid">36354718</article-id>
              <article-id pub-id-type="doi">10.3390/curroncol29110658</article-id>
              <article-id pub-id-type="publisher-id">curroncol-29-00658</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Impact of Adjunct Testosterone on Cancer-Related Fatigue: An Ancillary Analysis from a Controlled Randomized Trial</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0040-8693</contrib-id>
                  <name>
                    <surname>McGovern</surname>
                    <given-names>Kristen A.</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="c1-curroncol-29-00658" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Durham</surname>
                    <given-names>William J.</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7020-930X</contrib-id>
                  <name>
                    <surname>Wright</surname>
                    <given-names>Traver J.</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Dillon</surname>
                    <given-names>E. Lichar</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Randolph</surname>
                    <given-names>Kathleen M.</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Danesi</surname>
                    <given-names>Christopher P.</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Urban</surname>
                    <given-names>Randall J.</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6579-4655</contrib-id>
                  <name>
                    <surname>Sheffield-Moore</surname>
                    <given-names>Melinda</given-names>
                  </name>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing – review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                </contrib>
              </contrib-group>
              <aff id="af1-curroncol-29-00658">Department of Internal Medicine, The University of Texas Medical Branch (UTMB), 301 University Blvd., Galveston, TX 77555, USA</aff>
              <author-notes>
                <corresp id="c1-curroncol-29-00658"><label>*</label>Correspondence: <email>kamcgove@utmb.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>01</day>
                <month>11</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>11</month>
                <year>2022</year>
              </pub-date>
              <volume>29</volume>
              <issue>11</issue>
              <fpage>8340</fpage>
              <lpage>8356</lpage>
              <history>
                <date date-type="received">
                  <day>27</day>
                  <month>9</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>31</day>
                  <month>10</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 by the authors.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Many cancer patients undergoing treatment experience cancer-related fatigue (CRF). Inflammatory markers are correlated with CRF but are not routinely targeted for treatment. We previously demonstrated in an NIH-funded placebo-controlled, double-blind, randomized clinical trial (NCT00878995, closed to follow-up) that seven weekly injections of 100 mg adjunct testosterone preserved lean body mass in cancer patients undergoing standard-of-care treatment in a hospital setting. Because testosterone therapy can reduce circulating proinflammatory cytokines, we conducted an ancillary analysis to determine if this testosterone treatment reduced inflammatory burden and improved CRF symptoms and health-related quality of life. Randomization was computer-generated and managed by the pharmacy, which dispensed testosterone and placebo in opaque syringes to the administering study personnel. A total of 24 patients were randomized (14 placebo, 10 testosterone), and 21 were included in the primary analysis (11 placebo, 10 testosterone). Testosterone therapy did not ameliorate CRF symptoms (placebo to testosterone difference in predicted mean multidimensional fatigue symptom inventory scores: −5.6, 95% CI: −24.6 to 13.3), improve inflammatory markers, or preserve health-related quality of life and functional measures of performance in late-stage cancer patients. </p>
              </abstract>
              <kwd-group>
                <kwd>cancer</kwd>
                <kwd>CRF</kwd>
                <kwd>cytokines</kwd>
                <kwd>fatigue</kwd>
                <kwd>mood</kwd>
                <kwd>quality of life</kwd>
                <kwd>testosterone</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>National Cancer Institute</funding-source>
                  <award-id>RO1CA127971</award-id>
                </award-group>
                <award-group>
                  <funding-source>Institute for Translational Sciences at the University of Texas Medical Branch</funding-source>
                </award-group>
                <award-group>
                  <funding-source>National Center for Advancing Translational Sciences, National Institutes of Health</funding-source>
                  <award-id>UL1TR000071</award-id>
                </award-group>
                <funding-statement>This study was funded by a National Cancer Institute grant to M.S.-M. (RO1CA127971) and was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch, supported in part by a Clinical and Translational Science Award (UL1TR000071) from the National Center for Advancing Translational Sciences, National Institutes of Health.</funding-statement>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-curroncol-29-00658">
              <title>1. Introduction</title>
              <p>Cancer and associated treatments render many patients with fatigue, marked by a general perception of weariness, tiredness, and/or lack of energy. This cancer-related fatigue (CRF) is typically reported by cancer patients as their most distressing symptom [<xref rid="B1-curroncol-29-00658" ref-type="bibr">1</xref>,<xref rid="B2-curroncol-29-00658" ref-type="bibr">2</xref>,<xref rid="B3-curroncol-29-00658" ref-type="bibr">3</xref>,<xref rid="B4-curroncol-29-00658" ref-type="bibr">4</xref>,<xref rid="B5-curroncol-29-00658" ref-type="bibr">5</xref>]. Nearly all patients experience moderate to severe CRF at some point during therapy [<xref rid="B1-curroncol-29-00658" ref-type="bibr">1</xref>,<xref rid="B2-curroncol-29-00658" ref-type="bibr">2</xref>], and CRF severity is predictive of survival [<xref rid="B6-curroncol-29-00658" ref-type="bibr">6</xref>]. Because CRF is a significant implicit component in the clinical equation used to derive a cancer patient’s performance status [<xref rid="B6-curroncol-29-00658" ref-type="bibr">6</xref>,<xref rid="B7-curroncol-29-00658" ref-type="bibr">7</xref>,<xref rid="B8-curroncol-29-00658" ref-type="bibr">8</xref>,<xref rid="B9-curroncol-29-00658" ref-type="bibr">9</xref>], it is a critical determinant of treatment course [<xref rid="B10-curroncol-29-00658" ref-type="bibr">10</xref>].</p>
              <p>Despite the high incidence and prominence of CRF symptomatology, its etiology remains poorly defined [<xref rid="B2-curroncol-29-00658" ref-type="bibr">2</xref>,<xref rid="B11-curroncol-29-00658" ref-type="bibr">11</xref>,<xref rid="B12-curroncol-29-00658" ref-type="bibr">12</xref>]. Proposed factors mediating CRF include pro-inflammatory signaling [<xref rid="B2-curroncol-29-00658" ref-type="bibr">2</xref>,<xref rid="B11-curroncol-29-00658" ref-type="bibr">11</xref>,<xref rid="B13-curroncol-29-00658" ref-type="bibr">13</xref>,<xref rid="B14-curroncol-29-00658" ref-type="bibr">14</xref>,<xref rid="B15-curroncol-29-00658" ref-type="bibr">15</xref>,<xref rid="B16-curroncol-29-00658" ref-type="bibr">16</xref>], loss of skeletal muscle [<xref rid="B17-curroncol-29-00658" ref-type="bibr">17</xref>], circadian rhythm disruption [<xref rid="B18-curroncol-29-00658" ref-type="bibr">18</xref>], and hypothalamic-pituitary-adrenal axis disruption [<xref rid="B19-curroncol-29-00658" ref-type="bibr">19</xref>], but experimental support and mechanistic details for these and other factors remains limited [<xref rid="B19-curroncol-29-00658" ref-type="bibr">19</xref>].</p>
              <p>Given the poor understanding of the etiology of CRF, the lack of treatments for this symptom is perhaps unsurprising. While stimulants have been the most commonly employed pharmacological approach to treat CRF, many studies have reported no improvement, with increased incidence of adverse effects in some cases [<xref rid="B20-curroncol-29-00658" ref-type="bibr">20</xref>,<xref rid="B21-curroncol-29-00658" ref-type="bibr">21</xref>,<xref rid="B22-curroncol-29-00658" ref-type="bibr">22</xref>,<xref rid="B23-curroncol-29-00658" ref-type="bibr">23</xref>,<xref rid="B24-curroncol-29-00658" ref-type="bibr">24</xref>,<xref rid="B25-curroncol-29-00658" ref-type="bibr">25</xref>,<xref rid="B26-curroncol-29-00658" ref-type="bibr">26</xref>,<xref rid="B27-curroncol-29-00658" ref-type="bibr">27</xref>,<xref rid="B28-curroncol-29-00658" ref-type="bibr">28</xref>,<xref rid="B29-curroncol-29-00658" ref-type="bibr">29</xref>,<xref rid="B30-curroncol-29-00658" ref-type="bibr">30</xref>,<xref rid="B31-curroncol-29-00658" ref-type="bibr">31</xref>]. Many cancer patients receive glucocorticoid therapy to ameliorate treatment-related side effects, but with limited efficacy [<xref rid="B32-curroncol-29-00658" ref-type="bibr">32</xref>,<xref rid="B33-curroncol-29-00658" ref-type="bibr">33</xref>]. Regardless, glucocorticoid therapy is a short-term option at best for cancer-related fatigue, because prolonged use induces insulin resistance, increased adiposity [<xref rid="B34-curroncol-29-00658" ref-type="bibr">34</xref>,<xref rid="B35-curroncol-29-00658" ref-type="bibr">35</xref>,<xref rid="B36-curroncol-29-00658" ref-type="bibr">36</xref>], muscle wasting [<xref rid="B37-curroncol-29-00658" ref-type="bibr">37</xref>], brain atrophy, and diminished neurogenesis [<xref rid="B38-curroncol-29-00658" ref-type="bibr">38</xref>,<xref rid="B39-curroncol-29-00658" ref-type="bibr">39</xref>]. Chronic exercise training is the most effective treatment for CRF [<xref rid="B2-curroncol-29-00658" ref-type="bibr">2</xref>,<xref rid="B8-curroncol-29-00658" ref-type="bibr">8</xref>,<xref rid="B40-curroncol-29-00658" ref-type="bibr">40</xref>,<xref rid="B41-curroncol-29-00658" ref-type="bibr">41</xref>,<xref rid="B42-curroncol-29-00658" ref-type="bibr">42</xref>,<xref rid="B43-curroncol-29-00658" ref-type="bibr">43</xref>,<xref rid="B44-curroncol-29-00658" ref-type="bibr">44</xref>,<xref rid="B45-curroncol-29-00658" ref-type="bibr">45</xref>], suggesting that increased muscle activity triggers cellular and metabolic adaptations that counteract factors responsible for CRF. Although diet has received little attention in CRF, diet quality has been associated with reduced fatigue in a cross-sectional study of breast cancer survivors following primary treatment [<xref rid="B46-curroncol-29-00658" ref-type="bibr">46</xref>]. This may be due to dietary effects on the gut microbiome [<xref rid="B47-curroncol-29-00658" ref-type="bibr">47</xref>,<xref rid="B48-curroncol-29-00658" ref-type="bibr">48</xref>], which has been linked to fatigue in cancer patients and survivors [<xref rid="B49-curroncol-29-00658" ref-type="bibr">49</xref>,<xref rid="B50-curroncol-29-00658" ref-type="bibr">50</xref>].</p>
              <p>Adding further complexity to the etiology of CRF, cancer patients also exhibit a wasting phenotype called cancer cachexia, which is responsible for roughly one in five cancer deaths [<xref rid="B51-curroncol-29-00658" ref-type="bibr">51</xref>]. Cancer cachexia is characterized by persistent loss of skeletal muscle mass resulting in worsening functional impairment which cannot be restored via standard nutritional support [<xref rid="B52-curroncol-29-00658" ref-type="bibr">52</xref>]. CRF and cachexia share etiological factors including anorexia, inflammation, and inactivity [<xref rid="B53-curroncol-29-00658" ref-type="bibr">53</xref>], and may function synergistically to the detriment of cancer patients. </p>
              <p>By exploring potential treatments to ameliorate cancer-related symptoms common to both cachexia and fatigue, we aim to improve patient quality of life, expand treatment options, and increase time of survival. To that end, we previously demonstrated in a double-blind, placebo-controlled trial that weekly testosterone therapy preserved lean body mass in cervical and head and neck cancer patients with advanced or recurrent squamous cell carcinoma [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>]. In addition to its anti-catabolic properties, testosterone has been demonstrated to have anti-inflammatory effects. Testosterone levels negatively correlate with inflammatory markers [<xref rid="B55-curroncol-29-00658" ref-type="bibr">55</xref>] and testosterone therapy has been associated with decreases in serum levels of proinflammatory cytokines [<xref rid="B56-curroncol-29-00658" ref-type="bibr">56</xref>,<xref rid="B57-curroncol-29-00658" ref-type="bibr">57</xref>,<xref rid="B58-curroncol-29-00658" ref-type="bibr">58</xref>]. Because inflammatory markers and cachexia are associated with fatigue [<xref rid="B13-curroncol-29-00658" ref-type="bibr">13</xref>,<xref rid="B59-curroncol-29-00658" ref-type="bibr">59</xref>], we hypothesized that adjunct testosterone would improve fatigue symptoms and health-related quality of life through the mechanism of reducing inflammatory burden. In this planned ancillary analysis we report whether weekly testosterone therapy improves inflammatory markers, CRF symptom severity, and health-related quality of life. </p>
            </sec>
            <sec id="sec2-curroncol-29-00658">
              <title>2. Materials and Methods</title>
              <p>We conducted a randomized, double-blind, placebo-controlled clinical trial (National Clinical Trials number NCT00878995) which was approved by the Institutional Review Board at the University of Texas Medical Branch and carried out in conformity with the Declaration of Helsinki. All subjects provided written informed consent before enrollment and received standard-of-care therapy without restriction by the study team. The previously reported primary endpoint was the percent change in lean body mass during approximately 7 weeks of experimental intervention in cancer patients with advanced or recurrent squamous cell carcinoma of the cervix or head and neck [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>]. Power analysis for this primary outcome indicated that a sample size of 6–12 patients per group would provide power from 0.87 to &gt;0.99 to detect changes. Previously reported secondary outcomes were lean body mass, fat mass, energy expenditure, peak isometric strength, peak isokinetic strength, physical activity, quality of life, 1-year survival, energy intake, and select laboratory values. The experimental intervention consisted of weekly adjunct administration of either testosterone (100 mg) or placebo (sterile saline) injected intramuscularly during standard-of-care cancer treatment. Details of the study protocol, including timing of sampling, testosterone intervention paradigm, and patient eligibility, were presented previously, and are briefly discussed here.</p>
              <p>Patients were eligible for the study if they reported unintentional loss of at least 5% of body mass in the preceding 12 months and were either (1) 18 to 65 years of age and diagnosed with advanced or recurrent squamous cell carcinoma of the cervix (stages IIB, IIIA, IIIB, and IV), or (2) 18 to 75 years of age and diagnosed with advanced or recurrent head and neck squamous cell carcinoma. Eligibility requirements also included being ambulatory with some activity (Eastern Cooperative Oncology Group score of 0–1) and scoring at least 23 out of 30 on the Mini Mental State Examination [<xref rid="B2-curroncol-29-00658" ref-type="bibr">2</xref>], which was required to sign the study consent form.</p>
              <p>Eligible participants were recruited from April 2009 to April 2014. A total of 28 patients were screened for participation. Of these, 24 provided consent and were randomized using a computerized random number generator by the institutional research pharmacy in blocks of 3 to receive weekly intramuscular injections of either 100 mg of testosterone (<italic toggle="yes">N</italic> = 10) or placebo (<italic toggle="yes">N</italic> = 14). Recruitment was ended once 24 patients were randomized, in accordance with the sample size indicated by the previously mentioned power analysis. The UTMB Investigational Drug Service pharmacy managed study group assignment and dispensed testosterone and placebo in opaque syringes to the administering study personnel, who were blinded. Two patients stopped participating mid-study and one patient that was included in the initial report was excluded due to missing data for almost all measurements (<xref rid="curroncol-29-00658-f001" ref-type="fig">Figure 1</xref>). One female patient in the testosterone group met criteria for inclusion in this analysis, although she was excluded from the original report due to multiple primary tumors. Patients were followed up via monthly phone call for one year following the intervention. The final participant completed the intervention in June 2014; follow-up for all patients was completed by the end of June 2015. Adverse events were previously reported [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>]; no adverse events were reported for the additional participant included in this analysis.</p>
              <p>Patient data were collected at the University of Texas Medical Branch Institute for Translational Sciences Clinical Research Center in Galveston, TX. Standard-of-care and treatment schedule varied by participant, which was taken into consideration by the study protocol. Mean study duration was 47.8 ± 10 days in the placebo group and 47.0 ± 7.7 days in the testosterone group, with mid-treatment measures taken within 4.6 ± 4.1 days of each subject’s study midpoint, and post-treatment measures taken within 1.1 ± 3.7 days of the final experimental injection. </p>
              <sec id="sec2dot1-curroncol-29-00658">
                <title>2.1. Blood Sampling for Inflammatory Markers and Amino Acids</title>
                <p>Serum cytokine levels were measured pre- and post-intervention using the MILLIPLEX MAP Human High Sensitivity T-Cell Panel Premixed 13-plex—Immunology Multiplex Assay, following the manufacturer’s instructions. Concentrations of granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-gamma (IFN-γ), interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12, IL-13, and tumor necrosis factor (TNF-α) were determined. Sample measurements below the limit of detection were set to 0.5 * the detection limit. Serum amino acid concentrations were measured pre- and post-intervention using a Hitachi L8800 amino acid analyzer according to manufacturer guidelines.</p>
              </sec>
              <sec id="sec2dot2-curroncol-29-00658">
                <title>2.2. Questionnaires to Assess Fatigue, Mood, and Quality of Life</title>
                <sec id="sec2dot2dot1-curroncol-29-00658">
                  <title>2.2.1. Fatigue</title>
                  <p>Cancer-related fatigue was assessed using the MD Anderson Brief Fatigue Inventory (BFI) [<xref rid="B7-curroncol-29-00658" ref-type="bibr">7</xref>], a visual analog scale (VAS) for fatigue, and the Multidimensional Fatigue Symptom Inventory—Short Form [<xref rid="B60-curroncol-29-00658" ref-type="bibr">60</xref>] (MFSI). The BFI is a 9-item questionnaire assessing both the degree of cancer-related (perceptual) fatigue and how it interferes with various aspects of patients’ lives. The BFI assesses cancer-related fatigue at the present moment (“right now”), over the past 24 h, and over the past 7 days. The VAS for fatigue consists of a 10 cm horizontal line with the left extreme labeled “No fatigue” and the right extreme labeled “Extreme fatigue”. Patients were instructed to mark a vertical line at the point along the horizontal line that corresponded to their overall level of fatigue. The MFSI-SF consists of 30 statements for which cancer patients provide a self-rating of the extent of agreement. The items are rated on a 5-point scale, with 0 indicating the statement is not at all true with respect to their lives over the last 7 days and 4 indicating the statement is very true with respect to their lives over the last 7 days. The individual item responses are used to calculate empirically-derived subscales assessing general, physical, emotional, and mental fatigue, as well as vigor. Minimal clinically important difference criteria established in Asian breast cancer patients were used to determine whether subjects experienced clinically meaningful deterioration of fatigue between measurements [<xref rid="B61-curroncol-29-00658" ref-type="bibr">61</xref>]. Normative data for MFSI subscales is available separately for African American, Caucasian, and Hispanic adults [<xref rid="B62-curroncol-29-00658" ref-type="bibr">62</xref>,<xref rid="B63-curroncol-29-00658" ref-type="bibr">63</xref>], but there is no pooled normative data available. We did not have a sufficient sample size to conduct statistical comparisons using each of the normative data sets. In the interest of conducting a statistical comparison, and because the majority (&gt;70%) of study participants were Caucasian, pre-treatment MFSI subscale scores were compared to normative data for Caucasian adults [<xref rid="B62-curroncol-29-00658" ref-type="bibr">62</xref>]. </p>
                </sec>
                <sec id="sec2dot2dot2-curroncol-29-00658">
                  <title>2.2.2. Mood</title>
                  <p>Mood was assessed using the Profile of Mood States—Short Form [<xref rid="B64-curroncol-29-00658" ref-type="bibr">64</xref>] (POMS), which produces an overall score of mood disturbance as well as six subscales: tension-anxiety, depression–dejection, anger–hostility, vigor–activity, fatigue–inertia, and confusion–bewilderment. Pre-treatment POMS subscale scores of study participants were compared to normative data for adults &gt; 25 years of age [<xref rid="B65-curroncol-29-00658" ref-type="bibr">65</xref>].</p>
                </sec>
                <sec id="sec2dot2dot3-curroncol-29-00658">
                  <title>2.2.3. Health-Related Quality of Life</title>
                  <p>Health-related quality of life (QOL) was measured using the RAND 36-Item Health Survey 1.0 questionnaire [<xref rid="B66-curroncol-29-00658" ref-type="bibr">66</xref>] (SF-36); responses are used to construct 8 scales: physical functioning, emotional well-being, role limitations due to physical health, role limitations due to emotional problems, social functioning, energy/fatigue, pain, and general health. Pre-treatment SF-36 subscale scores of study participants were compared to normative data for adults [<xref rid="B67-curroncol-29-00658" ref-type="bibr">67</xref>]. The MD Anderson Symptom Inventory [<xref rid="B3-curroncol-29-00658" ref-type="bibr">3</xref>] (MDASI) was also administered, with responses used to construct scores for symptom severity and interference. Nausea was measured using a VAS format similar to the VAS for fatigue. Functional Assessment of Cancer Therapy [<xref rid="B68-curroncol-29-00658" ref-type="bibr">68</xref>] (FACT-G) questionnaire scores were previously reported [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>], and are included here in supporting correlative analyses and characterizations.</p>
                  <p>The MFSI, SF-36, and POMS questionnaires were administered at the pre-, mid-, and post-treatment time points. Missing responses on completed questionnaires were minimal (&lt;1%) and were imputed for the MFSI and POMS using the average of the participant’s remaining responses for the applicable subscale for a maximum of one question per subscale [<xref rid="B69-curroncol-29-00658" ref-type="bibr">69</xref>]. The BFI, MDASI, and VAS questionnaires were administered daily over the course of the intervention and averaged by week; weekly scores were included in analyses if a minimum of one questionnaire was completed for that week.</p>
                </sec>
              </sec>
              <sec id="sec2dot3-curroncol-29-00658">
                <title>2.3. Statistical Analyses</title>
                <p>Statistical analyses were conducted using GraphPad Prism (Version 9.4.1; GraphPad Software, La Jolla, CA, USA) and R (Version 4.2.1); the threshold for statistical significance was set at <italic toggle="yes">p</italic> &lt; 0.05. Groupwise comparisons of continuous and discrete demographics variables were analyzed using unpaired Welch’s <italic toggle="yes">t</italic>-tests and Fisher’s exact test, respectively. Average percent changes from baseline to post-treatment were determined for serum cytokine concentrations and compared between the testosterone and placebo groups using unpaired Welch’s <italic toggle="yes">t</italic>-tests; <italic toggle="yes">p</italic>-values were adjusted for multiple testing using a Holm–Šídák correction. Only patients with both baseline and post-treatment serum cytokine measurements were included in this analysis. Linear mixed effects models (with Geisser–Greenhouse correction) were used to test the main effects of treatment (placebo vs. testosterone) and time point (pre, mid, and post), as well as the interaction effect of treatment by time point on questionnaire scores and subscales; <italic toggle="yes">p</italic>-values were adjusted for multiple testing using a Bonferroni correction. Linear mixed effects models are maximum likelihood approaches suitable for assessing effects when data are missing. Data for all patients were included in these analyses; missing values for each model are reported in the <xref rid="app1-curroncol-29-00658" ref-type="app">Supplementary Materials</xref>. Pre-treatment scores for the MFSI, SF-36, and POMS questionnaires were compared to normative data from previous studies in the literature using unpaired Welch’s <italic toggle="yes">t</italic>-tests; <italic toggle="yes">p</italic>-values were adjusted for multiple testing using a Holm–Šídák correction.</p>
                <p>In an exploratory analysis, data were pooled and a Spearman’s rank correlation heat map was created to identify correlations among baseline serum cytokine levels and questionnaire scores. Correlation coefficients exceeding an absolute value of 0.7 with <italic toggle="yes">p</italic> &lt; 0.05 are presented in the text. Due to the exploratory nature of this analysis, <italic toggle="yes">p</italic>-values for correlations were not corrected for multiple testing.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-curroncol-29-00658">
              <title>3. Results</title>
              <sec id="sec3dot1-curroncol-29-00658">
                <title>3.1. Baseline Demographics</title>
                <p>Baseline demographics, including age, body mass, and BMI, as well as the distributions of sex, race, cancer type and tumor stage, were similar between placebo and testosterone groups (<xref rid="curroncol-29-00658-t001" ref-type="table">Table 1</xref>). Kaplan–Meier survival curves were not significantly different between groups, and were similar to previously reported curves with a slightly different patient set [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>] (<xref rid="app1-curroncol-29-00658" ref-type="app">Figure S1</xref>).</p>
              </sec>
              <sec id="sec3dot2-curroncol-29-00658">
                <title>3.2. Correlations of Baseline Cytokine Levels with Questionnaire Scores</title>
                <p>Baseline cytokine levels were significantly correlated with questionnaire scores evaluating patient self-assessment of fatigue, mood, and symptom severity (<xref rid="curroncol-29-00658-f002" ref-type="fig">Figure 2</xref>). Significant correlations with |r| ≥ 0.7 are listed. IFN-γ was correlated with the MFSI Vigor subscale (r = −0.71, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 18). IL-4 was correlated with MDASI Interference (r = 0.74, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 17). IL-6 was correlated with the MFSI Emotional subscale (r = 0.75, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 18) and Total score (r = 0.82, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 18), the SF-36 Social Functioning scale (r = −0.71, <italic toggle="yes">p</italic> = 0.002, <italic toggle="yes">n</italic> = 16), the POMS Depression (r = 0.70, <italic toggle="yes">p</italic> = 0.001, <italic toggle="yes">n</italic> = 18) and Fatigue (r = 0.71, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 18) subscales and Total Mood Disturbance score (r = 0.77, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 17), MDASI Severity (r = 0.80, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 17), and VAS Fatigue (r = 0.71, <italic toggle="yes">p</italic> = 0.002, <italic toggle="yes">n</italic> = 16). IL-7 was correlated with the POMS Depression subscale (r = 0.72, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 18) and MDASI Severity (r = 0.75, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 17). IL-12 was correlated with VAS Nausea (r = 0.75, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 17). IL-13 was correlated with the MFSI Vigor subscale (r = −0.75, <italic toggle="yes">p</italic> &lt; 0.001, <italic toggle="yes">n</italic> = 18) and the SF-36 Social Functioning subscale (r = −0.75, <italic toggle="yes">p</italic> = 0.001, <italic toggle="yes">n</italic> = 16).</p>
              </sec>
              <sec id="sec3dot3-curroncol-29-00658">
                <title>3.3. Comparisons of Baseline Questionnaire Scores to Normative Data</title>
                <p>Baseline MFSI subscale scores of study participants were not significantly different from previously published normative data (<xref rid="curroncol-29-00658-t002" ref-type="table">Table 2</xref>). Baseline POMS Vigor scores for cervical or head and neck cancer patients were significantly lower than those of normative subjects, indicating greater symptom severity. Other POMS subscale and POMS Total Mood Disturbance scores were not significantly different from those of normative subjects (<xref rid="curroncol-29-00658-t002" ref-type="table">Table 2</xref>). Baseline measures of SF-36 Physical Functioning, Role Limitations Due to Physical Health, and Social Functioning subscales for cervical or head and neck cancer patients were significantly lower than those of normative subjects, indicating greater symptom severity. Other SF-36 subscale scores were not significantly different from those of normative subjects (<xref rid="curroncol-29-00658-t002" ref-type="table">Table 2</xref>).</p>
              </sec>
              <sec id="sec3dot4-curroncol-29-00658">
                <title>3.4. Serum Cytokine Levels</title>
                <p>Serum cytokine levels were highly variable in the placebo and testosterone groups at baseline and post-treatment (<xref rid="app1-curroncol-29-00658" ref-type="app">Table S1</xref>). There were no significant differences between groups in percent changes of serum cytokine concentrations from baseline to post-treatment (<xref rid="curroncol-29-00658-f003" ref-type="fig">Figure 3</xref>, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S2</xref>).</p>
              </sec>
              <sec id="sec3dot5-curroncol-29-00658">
                <title>3.5. Serum Amino Acid Levels</title>
                <p>Baseline and post-treatment serum amino acid concentrations are presented in <xref rid="app1-curroncol-29-00658" ref-type="app">Table S4</xref>. There were no differences in percent change of serum amino acid and associated metabolite concentrations from baseline to post-treatment between the placebo (<italic toggle="yes">n</italic> = 9) and testosterone (<italic toggle="yes">n</italic> = 9) groups (<xref rid="app1-curroncol-29-00658" ref-type="app">Figure S2, Table S5</xref>).</p>
              </sec>
              <sec id="sec3dot6-curroncol-29-00658">
                <title>3.6. Effects of Treatment and Time Point on Fatigue, Mood, and Quality of Life</title>
                <sec id="sec3dot6dot1-curroncol-29-00658">
                  <title>3.6.1. Fatigue</title>
                  <p>The linear mixed effects model results demonstrated no significant main effects of treatment or time and no significant interaction effect of treatment by time for weekly averaged BFI or VAS Fatigue scores over the 7-week intervention (<xref rid="curroncol-29-00658-f004" ref-type="fig">Figure 4</xref>A,B, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S3</xref>). There were no significant differences in pre-, mid-, and post-treatment MFSI total scores or associated subscales (Vigor, as well as General, Physical, Emotional, and Mental fatigue) between treatment groups or longitudinally within groups (<xref rid="curroncol-29-00658-f005" ref-type="fig">Figure 5</xref>, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S3</xref>). Based on previously established criteria for minimal clinically important difference (increase in MFSI total score &gt; 10.79), 40% of the placebo group and 37.5% of the testosterone group had a clinically significant increase in perceived fatigue between the pre- and post-treatment time points [<xref rid="B61-curroncol-29-00658" ref-type="bibr">61</xref>].</p>
                </sec>
                <sec id="sec3dot6dot2-curroncol-29-00658">
                  <title>3.6.2. Mood</title>
                  <p>There were no significant main effects of treatment or time and no significant treatment by time interaction effect for POMS total scores and subscales (including Tension–Anxiety, Depression, Anger–Hostility, Vigor, Fatigue, Confusion, and Total Mood Disturbance) over the 7-week study (<xref rid="curroncol-29-00658-f006" ref-type="fig">Figure 6</xref>, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S3</xref>).</p>
                </sec>
                <sec id="sec3dot6dot3-curroncol-29-00658">
                  <title>3.6.3. Health-Related Quality of Life</title>
                  <p>There were no significant differences in pre-, mid-, and post-treatment SF-36 subscales, including Physical Functioning, Energy/Fatigue, Emotional Well Being, Social Functioning, Pain, and General Health, between groups or longitudinally within groups over the 7-week intervention (<xref rid="curroncol-29-00658-f007" ref-type="fig">Figure 7</xref>, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S3</xref>). There were no significant main effects of treatment or time and no significant interaction effect of time by treatment for weekly averaged VAS Nausea scores (<xref rid="curroncol-29-00658-f004" ref-type="fig">Figure 4</xref>C, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S3</xref>) or MDASI Severity or Interference scales over the 7-week intervention (<xref rid="curroncol-29-00658-f004" ref-type="fig">Figure 4</xref>D,E, <xref rid="app1-curroncol-29-00658" ref-type="app">Table S3</xref>).</p>
                </sec>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-curroncol-29-00658">
              <title>4. Discussion</title>
              <p>Previously, we demonstrated that adjunct testosterone preserved lean body mass and improved SPPB scores, but did not alter peak power or torque generated by leg extension in cervical or head and neck cancer patients undergoing standard-of-care treatment [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>]. Here, we show that despite its anti-catabolic effects, seven weeks of adjunct testosterone did not improve inflammatory markers and did not ameliorate CRF in these patients.</p>
              <p>Care should be taken to distinguish between peripheral and central fatigue. While peripheral fatigue is associated with physical exhaustion and occurs within the muscle [<xref rid="B70-curroncol-29-00658" ref-type="bibr">70</xref>,<xref rid="B71-curroncol-29-00658" ref-type="bibr">71</xref>,<xref rid="B72-curroncol-29-00658" ref-type="bibr">72</xref>,<xref rid="B73-curroncol-29-00658" ref-type="bibr">73</xref>,<xref rid="B74-curroncol-29-00658" ref-type="bibr">74</xref>], central fatigue originates in the central nervous system and encompasses the cognitive element of mental fatigue [<xref rid="B75-curroncol-29-00658" ref-type="bibr">75</xref>,<xref rid="B76-curroncol-29-00658" ref-type="bibr">76</xref>]. Previous research indicates that CRF is central in origin [<xref rid="B70-curroncol-29-00658" ref-type="bibr">70</xref>,<xref rid="B77-curroncol-29-00658" ref-type="bibr">77</xref>]. Only a portion of cancer patients develop CRF, which is presumably caused by an aggregation of physical and psychosocial risk factors, with some individuals likely more susceptible than others [<xref rid="B11-curroncol-29-00658" ref-type="bibr">11</xref>].</p>
              <p>In this study, baseline objective measures (i.e., cytokine levels) were highly correlated with subjective measures of fatigue, mood, health-related quality of life, and symptom severity and interference. However, it is important to note that the <italic toggle="yes">p</italic>-values for this exploratory analysis were not adjusted for multiple testing. The cytokine that was most highly correlated with fatigue and neuropsychological measures at baseline in the cervical and head and neck cancer patients in this study was IL-6. Serum IL-6 has previously been observed to be elevated in cancer patients compared to controls [<xref rid="B78-curroncol-29-00658" ref-type="bibr">78</xref>] and has been linked to tumor burden and fatigue in cancer patients, both pre- and post-treatment [<xref rid="B15-curroncol-29-00658" ref-type="bibr">15</xref>,<xref rid="B79-curroncol-29-00658" ref-type="bibr">79</xref>,<xref rid="B80-curroncol-29-00658" ref-type="bibr">80</xref>]. High serum IL-6 levels can indicate poor prognosis in breast cancer patients [<xref rid="B81-curroncol-29-00658" ref-type="bibr">81</xref>], and has also been correlated with fatigue in other conditions [<xref rid="B82-curroncol-29-00658" ref-type="bibr">82</xref>,<xref rid="B83-curroncol-29-00658" ref-type="bibr">83</xref>]. Low doses of IL-6 administered to healthy male volunteers resulted in higher reported fatigue, diminished ability to concentrate, and reduced REM sleep [<xref rid="B84-curroncol-29-00658" ref-type="bibr">84</xref>].</p>
              <p>Cytokine levels did not change significantly over the course of treatment. Although testosterone has demonstrated anti-inflammatory effects via reduction of cytokine concentrations in previous studies [<xref rid="B56-curroncol-29-00658" ref-type="bibr">56</xref>,<xref rid="B57-curroncol-29-00658" ref-type="bibr">57</xref>,<xref rid="B58-curroncol-29-00658" ref-type="bibr">58</xref>], it did not suppress inflammatory cytokine burden in this study. This is likely due to the combined effects of cancer and its treatment on cytokine levels. Pro-inflammatory cytokines can be secreted in response to the tumor itself or in response to cancer therapy [<xref rid="B13-curroncol-29-00658" ref-type="bibr">13</xref>,<xref rid="B85-curroncol-29-00658" ref-type="bibr">85</xref>] and can be secreted from cancer cells, immune cells, or nervous system cells [<xref rid="B14-curroncol-29-00658" ref-type="bibr">14</xref>]. Any decrease in cytokine secretion due to reduction of tumor mass following chemotherapy or radiation was likely offset by an increase in cytokines due to the treatment. Men and women received the same dose (100 mg) of testosterone in this study [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>]. While this is a typical dose to treat hypogonadism in men, it is a hyper-physiological dose for women.</p>
              <p>Recent research suggests that the complex of symptoms affecting fatigue, cognition, and mood in cancer patients might be present prior to standard-of-care treatment [<xref rid="B86-curroncol-29-00658" ref-type="bibr">86</xref>,<xref rid="B87-curroncol-29-00658" ref-type="bibr">87</xref>,<xref rid="B88-curroncol-29-00658" ref-type="bibr">88</xref>,<xref rid="B89-curroncol-29-00658" ref-type="bibr">89</xref>,<xref rid="B90-curroncol-29-00658" ref-type="bibr">90</xref>,<xref rid="B91-curroncol-29-00658" ref-type="bibr">91</xref>,<xref rid="B92-curroncol-29-00658" ref-type="bibr">92</xref>,<xref rid="B93-curroncol-29-00658" ref-type="bibr">93</xref>,<xref rid="B94-curroncol-29-00658" ref-type="bibr">94</xref>]. Compared to normative data, cancer patients in this study reported significantly greater symptom severity at baseline for questionnaire subscales corresponding to vigor, physical and social functioning, and role limitations due to physical health following adjustment for multiple testing. Cancer patients in this study also reported greater symptom severity at baseline for questionnaire scores corresponding to emotional fatigue, energy/fatigue, tension–anxiety, and total mood disturbance, although these comparisons were not significant after correcting for multiple testing. Although our previous results indicated that testosterone therapy resulted in clinically meaningful improvements in the FACT-G questionnaire total score and social/family well-being subscale [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>], adjunct testosterone did not improve fatigue, mood, health-related quality of life, or symptom severity and interference outcomes reported in this analysis. Not only were fatigue and other measures assessed by questionnaire unaltered by testosterone therapy in this study, they were unchanged over the course of standard-of-care treatment. This might reflect the advanced stage of many of the patients in this trial.</p>
              <p>CRF and other complex cancer-related symptom clusters are unlikely to be fully predicted exclusively by individual cytokines or inflammatory markers. CRF has a strong association with cancer-related cognitive impairment (CRCI) [<xref rid="B95-curroncol-29-00658" ref-type="bibr">95</xref>], another distressing symptom experienced by up to 75% of patients undergoing cancer treatment [<xref rid="B96-curroncol-29-00658" ref-type="bibr">96</xref>]. CRCI is characterized by deficiencies in various cognitive domains including concentration, attention, and executive function [<xref rid="B96-curroncol-29-00658" ref-type="bibr">96</xref>]. Possible factors mediating CRCI include activation of microglia, which may block neurogenesis or alter neural impulse time [<xref rid="B97-curroncol-29-00658" ref-type="bibr">97</xref>], hippocampal shrinkage caused by glucocorticoids [<xref rid="B38-curroncol-29-00658" ref-type="bibr">38</xref>,<xref rid="B39-curroncol-29-00658" ref-type="bibr">39</xref>], and effects from chemotherapy such as hippocampal oxidative damage [<xref rid="B85-curroncol-29-00658" ref-type="bibr">85</xref>] and neuroinflammation, which is linked to cognitive impairment due to alterations in myelin structure and myelination [<xref rid="B98-curroncol-29-00658" ref-type="bibr">98</xref>]. The absence of standardized assessments for CRCI [<xref rid="B99-curroncol-29-00658" ref-type="bibr">99</xref>] and limited association between patient-perceived cognitive changes and neurocognitive test results [<xref rid="B100-curroncol-29-00658" ref-type="bibr">100</xref>] make it difficult to identify, measure, and track CRCI in cancer patients.</p>
              <p>Cancer patients also experience alterations to the gut microbiome as a result of both chemotherapy [<xref rid="B101-curroncol-29-00658" ref-type="bibr">101</xref>,<xref rid="B102-curroncol-29-00658" ref-type="bibr">102</xref>] and the cancer itself [<xref rid="B103-curroncol-29-00658" ref-type="bibr">103</xref>]. We have observed a similar constellation of symptoms, including fatigue and cognitive impairment, in some patients with traumatic brain injury, and these patients additionally present with an altered gut microbiome and growth hormone deficiency [<xref rid="B104-curroncol-29-00658" ref-type="bibr">104</xref>,<xref rid="B105-curroncol-29-00658" ref-type="bibr">105</xref>]. Comparable symptoms of fatigue, cognitive dysfunction, and gut microbiome changes have been observed in patients with post-acute sequelae of SARS-CoV-2 infection, or “long Covid” [<xref rid="B106-curroncol-29-00658" ref-type="bibr">106</xref>,<xref rid="B107-curroncol-29-00658" ref-type="bibr">107</xref>], and chronic fatigue syndrome [<xref rid="B108-curroncol-29-00658" ref-type="bibr">108</xref>,<xref rid="B109-curroncol-29-00658" ref-type="bibr">109</xref>], among other disorders [<xref rid="B110-curroncol-29-00658" ref-type="bibr">110</xref>,<xref rid="B111-curroncol-29-00658" ref-type="bibr">111</xref>,<xref rid="B112-curroncol-29-00658" ref-type="bibr">112</xref>]. While one study found no differences in gut microbiome diversity based on level of fatigue [<xref rid="B113-curroncol-29-00658" ref-type="bibr">113</xref>], two studies did report an association between fatigue and changes to the gut microbiome in cancer patients or survivors [<xref rid="B49-curroncol-29-00658" ref-type="bibr">49</xref>,<xref rid="B50-curroncol-29-00658" ref-type="bibr">50</xref>]. Additionally, one of these studies found that patients in the high fatigue group had a greater abundance of taxa linked to inflammation [<xref rid="B50-curroncol-29-00658" ref-type="bibr">50</xref>], while the other found that relative abundance of certain taxa correlated with neurocognitive capacity in cancer survivors [<xref rid="B49-curroncol-29-00658" ref-type="bibr">49</xref>].</p>
              <sec>
                <title>Study Limitations</title>
                <p>A chief limitation to this study was the small number of study participants. This study was originally powered based on the primary outcome of change in lean body mass following testosterone therapy [<xref rid="B54-curroncol-29-00658" ref-type="bibr">54</xref>] and was not directly powered for the secondary outcomes presented here. The main outcome in this ancillary analysis was perceptual fatigue as assessed by the MFSI Total Score. There was no trend in fatigue scores observed over the course of the study, so it is unknown whether a difference would have been detected with a larger sample size. The testosterone group scored slightly higher than the placebo group at baseline and the post-treatment timepoint, but slightly lower at the study mid-point. Another limitation was that there was missing outcome data for some of the measures, so individual patients may be included in some analyses but not others.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec5-curroncol-29-00658">
              <title>5. Conclusions</title>
              <p>Despite preserving lean body mass, testosterone treatment did not reduce inflammatory burden, improve fatigue, or preserve health-related quality of life and functional measures of performance in late-stage cancer patients. This discrepancy suggests that these factors are independent and should be considered individually when devising a clinical treatment plan for patients. Further studies are needed to elucidate mechanisms contributing to the symptom complex of CRF, CRCI, and mood disturbance in cancer patients prior to, during, and following primary and adjuvant therapy. The role of the microbiome in the etiology of these symptoms warrants further investigation.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>We thank all participating physicians, nurses, and staff from UTMB and MD Anderson Cancer Center, as well as staff from the Institute for Translational Sciences Clinical Research Center, the UTMB Mass Spectrometry Facility, and the UTMB Investigational Drug Service Pharmacy. We thank all the patients who gave their time to this study to benefit the care of all.</p>
            </ack>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <app-group>
              <app id="app1-curroncol-29-00658">
                <title>Supplementary Materials</title>
                <p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/curroncol29110658/s1">https://www.mdpi.com/article/10.3390/curroncol29110658/s1</uri>, Figure S1: Overall survival of cervical or head and neck cancer patients for one year following 7 weeks of adjunct testosterone or placebo, Figure S2: Percent change (average ± SD) in amino acid and associated metabolite concentrations from baseline to post-treatment for cancer patients receiving testosterone or placebo, Table S1: Serum cytokine concentrations at baseline and post-treatment in cancer patients receiving testosterone or placebo, Table S2: Welch’s <italic toggle="yes">t</italic>-test results comparing the percent change of serum cytokine concentrations from baseline to post-treatment between placebo and testosterone groups, Table S3: Mixed effects models results assessing the effects of time and treatment on questionnaire scores for cancer patients receiving testosterone or placebo, Table S4: Serum amino acid and associated metabolite concentrations at baseline and post-treatment in cancer patients receiving testosterone or placebo, and Table S5: Welch’s <italic toggle="yes">t</italic>-test results comparing the percent change of serum amino acid and associated metabolite concentrations from baseline to post-treatment between placebo and testosterone groups.</p>
                <supplementary-material id="curroncol-29-00658-s001" position="float" content-type="local-data">
                  <media xlink:href="curroncol-29-00658-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, M.S.-M.; methodology, M.S.-M. and R.J.U.; software, M.S.-M.; validation, C.P.D., K.A.M. and K.M.R.; formal analysis, K.A.M.; investigation, C.P.D., E.L.D., K.M.R., M.S.-M. and W.J.D.; resources, M.S.-M. and R.J.U.; data curation, K.A.M., K.M.R., T.J.W. and W.J.D.; writing—original draft preparation, K.A.M., T.J.W. and W.J.D.; writing—review and editing, C.P.D., E.L.D., K.M.R., M.S.-M. and R.J.U.; visualization, K.A.M., K.M.R. and T.J.W.; supervision, M.S.-M. and R.J.U.; project administration, M.S.-M.; funding acquisition, M.S.-M. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>This study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Institutional Review Board of the University of Texas Medical Branch (<uri>http:/clinicaltrials.gov</uri> number NCT00878995, first posted on 9 April 2009).</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Informed consent was obtained from all subjects involved in the study.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>The data presented in this study are available on request from the corresponding author.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-curroncol-29-00658">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vogelzang</surname>
                      <given-names>N.J.</given-names>
                    </name>
                    <name>
                      <surname>Breitbart</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Cella</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Curt</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Groopman</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Horning</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Itri</surname>
                      <given-names>L.M.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>D.H.</given-names>
                    </name>
                    <name>
                      <surname>Scherr</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Portenoy</surname>
                      <given-names>R.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Patient, Caregiver, and Oncologist Perceptions of Cancer-Related Fatigue: Results of a Tripart Assessment Survey. The Fatigue Coalition</article-title>
                  <source>Semin. Hematol.</source>
                  <year>1997</year>
                  <volume>34</volume>
                  <fpage>4</fpage>
                  <lpage>12</lpage>
                  <pub-id pub-id-type="pmid">9253778</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-curroncol-29-00658">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mortimer</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Barsevick</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>C.L.</given-names>
                    </name>
                    <name>
                      <surname>Berger</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>De Vader</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Escalante</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gilreath</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hurria</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Mendoza</surname>
                      <given-names>T.R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee</article-title>
                  <source>J. Natl. Compr. Cancer Netw.</source>
                  <year>2010</year>
                  <volume>8</volume>
                  <fpage>1331</fpage>
                  <lpage>1339</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2010.0101</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-curroncol-29-00658">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Mendoza</surname>
                      <given-names>T.R.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                    <name>
                      <surname>Chou</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Harle</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Morrissey</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Engstrom</surname>
                      <given-names>M.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Assessing Symptom Distress in Cancer Patients: The MD Anderson Symptom Inventory</article-title>
                  <source>Cancer</source>
                  <year>2000</year>
                  <volume>89</volume>
                  <fpage>1634</fpage>
                  <lpage>1646</lpage>
                  <pub-id pub-id-type="doi">10.1002/1097-0142(20001001)89:7&lt;1634::AID-CNCR29&gt;3.0.CO;2-V</pub-id>
                  <pub-id pub-id-type="pmid">11013380</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-curroncol-29-00658">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barsevick</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Manning</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>O’Mara</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Reeve</surname>
                      <given-names>B.B.</given-names>
                    </name>
                    <name>
                      <surname>Scott</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Sloan</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes) ASCPRO Recommendations for the Assessment of Fatigue as an Outcome in Clinical Trials</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2010</year>
                  <volume>39</volume>
                  <fpage>1086</fpage>
                  <lpage>1099</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2010.02.006</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-curroncol-29-00658">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Butt</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Rosenbloom</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Abernethy</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Beaumont</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Paul</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Hampton</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Jacobsen</surname>
                      <given-names>P.B.</given-names>
                    </name>
                    <name>
                      <surname>Syrjala</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Von Roenn</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Cella</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fatigue Is the Most Important Symptom for Advanced Cancer Patients Who Have Had Chemotherapy</article-title>
                  <source>J. Natl. Compr. Cancer Netw.</source>
                  <year>2008</year>
                  <volume>6</volume>
                  <fpage>448</fpage>
                  <lpage>455</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2008.0036</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-curroncol-29-00658">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hwang</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>V.T.</given-names>
                    </name>
                    <name>
                      <surname>Cogswell</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kasimis</surname>
                      <given-names>B.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical Relevance of Fatigue Levels in Cancer Patients at a Veterans Administration Medical Center</article-title>
                  <source>Cancer</source>
                  <year>2002</year>
                  <volume>94</volume>
                  <fpage>2481</fpage>
                  <lpage>2489</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.10507</pub-id>
                  <pub-id pub-id-type="pmid">12015774</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-curroncol-29-00658">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mendoza</surname>
                      <given-names>T.R.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Morrissey</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>B.A.</given-names>
                    </name>
                    <name>
                      <surname>Wendt</surname>
                      <given-names>J.K.</given-names>
                    </name>
                    <name>
                      <surname>Huber</surname>
                      <given-names>S.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Rapid Assessment of Fatigue Severity in Cancer Patients: Use of the Brief Fatigue Inventory</article-title>
                  <source>Cancer</source>
                  <year>1999</year>
                  <volume>85</volume>
                  <fpage>1186</fpage>
                  <lpage>1196</lpage>
                  <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19990301)85:5&lt;1186::AID-CNCR24&gt;3.0.CO;2-N</pub-id>
                  <pub-id pub-id-type="pmid">10091805</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-curroncol-29-00658">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                    <name>
                      <surname>Hao</surname>
                      <given-names>X.-S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>Y.-Q.</given-names>
                    </name>
                    <name>
                      <surname>Mendoza</surname>
                      <given-names>T.R.</given-names>
                    </name>
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Validation Study of the Chinese Version of the Brief Fatigue Inventory (BFI-C)</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2004</year>
                  <volume>27</volume>
                  <fpage>322</fpage>
                  <lpage>332</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2003.09.008</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-curroncol-29-00658">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yun</surname>
                      <given-names>Y.H.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Roh</surname>
                      <given-names>J.W.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>C.G.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>W.S.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Bang</surname>
                      <given-names>S.-M.</given-names>
                    </name>
                    <name>
                      <surname>Mendoza</surname>
                      <given-names>T.R.</given-names>
                    </name>
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Validation Study of the Korean Version of the Brief Fatigue Inventory</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2005</year>
                  <volume>29</volume>
                  <fpage>165</fpage>
                  <lpage>172</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2004.04.013</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-curroncol-29-00658">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mantovani</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Macciò</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Madeddu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gramignano</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lusso</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Serpe</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Massa</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Astara</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Deiana</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Phase II Study with Antioxidants, Both in the Diet and Supplemented, Pharmaconutritional Support, Progestagen, and Anti-Cyclooxygenase-2 Showing Efficacy and Safety in Patients with Cancer-Related Anorexia/Cachexia and Oxidative Stress</article-title>
                  <source>Cancer Epidemiol. Biomark. Prev.</source>
                  <year>2006</year>
                  <volume>15</volume>
                  <fpage>1030</fpage>
                  <lpage>1034</lpage>
                  <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0538</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-curroncol-29-00658">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pathophysiology of Cancer-Related Fatigue</article-title>
                  <source>Clin. J. Oncol. Nurs.</source>
                  <year>2008</year>
                  <volume>12</volume>
                  <fpage>11</fpage>
                  <lpage>20</lpage>
                  <pub-id pub-id-type="doi">10.1188/08.CJON.S2.11-20</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-curroncol-29-00658">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yang</surname>
                      <given-names>T.-Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>M.-L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.-C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of an Aerobic Exercise Programme on Fatigue for Patients with Breast Cancer Undergoing Radiotherapy</article-title>
                  <source>J. Clin. Nurs.</source>
                  <year>2015</year>
                  <volume>24</volume>
                  <fpage>202</fpage>
                  <lpage>211</lpage>
                  <pub-id pub-id-type="doi">10.1111/jocn.12672</pub-id>
                  <pub-id pub-id-type="pmid">25257238</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-curroncol-29-00658">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bower</surname>
                      <given-names>J.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer-Related Fatigue: Links with Inflammation in Cancer Patients and Survivors</article-title>
                  <source>Brain Behav. Immun.</source>
                  <year>2007</year>
                  <volume>21</volume>
                  <fpage>863</fpage>
                  <lpage>871</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2007.03.013</pub-id>
                  <pub-id pub-id-type="pmid">17543499</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-curroncol-29-00658">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>G.J.</given-names>
                    </name>
                    <name>
                      <surname>Dantzer</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Dougherty</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Dunn</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Meyers</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Miller</surname>
                      <given-names>A.H.</given-names>
                    </name>
                    <name>
                      <surname>Payne</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Reuben</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Are the Symptoms of Cancer and Cancer Treatment Due to a Shared Biologic Mechanism? A Cytokine-Immunologic Model of Cancer Symptoms</article-title>
                  <source>Cancer</source>
                  <year>2003</year>
                  <volume>97</volume>
                  <fpage>2919</fpage>
                  <lpage>2925</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.11382</pub-id>
                  <pub-id pub-id-type="pmid">12767108</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-curroncol-29-00658">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schubert</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Hong</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Natarajan</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Mills</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Dimsdale</surname>
                      <given-names>J.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Association between Fatigue and Inflammatory Marker Levels in Cancer Patients: A Quantitative Review</article-title>
                  <source>Brain Behav. Immun.</source>
                  <year>2007</year>
                  <volume>21</volume>
                  <fpage>413</fpage>
                  <lpage>427</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2006.11.004</pub-id>
                  <pub-id pub-id-type="pmid">17178209</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-curroncol-29-00658">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barsevick</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Frost</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zwinderman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hall</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Halyard</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>GENEQOL Consortium I’m so Tired: Biological and Genetic Mechanisms of Cancer-Related Fatigue</article-title>
                  <source>Qual. Life Res.</source>
                  <year>2010</year>
                  <volume>19</volume>
                  <fpage>1419</fpage>
                  <lpage>1427</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11136-010-9757-7</pub-id>
                  <pub-id pub-id-type="pmid">20953908</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-curroncol-29-00658">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Al-Majid</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>D.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise</article-title>
                  <source>Biol. Res. Nurs.</source>
                  <year>2001</year>
                  <volume>2</volume>
                  <fpage>186</fpage>
                  <lpage>197</lpage>
                  <pub-id pub-id-type="doi">10.1177/109980040100200304</pub-id>
                  <pub-id pub-id-type="pmid">11547540</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-curroncol-29-00658">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berger</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Wielgus</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hertzog</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fischer</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Farr</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Patterns of Circadian Activity Rhythms and Their Relationships with Fatigue and Anxiety/Depression in Women Treated with Breast Cancer Adjuvant Chemotherapy</article-title>
                  <source>Support. Care Cancer</source>
                  <year>2010</year>
                  <volume>18</volume>
                  <fpage>105</fpage>
                  <lpage>114</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00520-009-0636-0</pub-id>
                  <pub-id pub-id-type="pmid">19381692</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-curroncol-29-00658">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berger</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Mooney</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Alvarez-Perez</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Breitbart</surname>
                      <given-names>W.S.</given-names>
                    </name>
                    <name>
                      <surname>Carpenter</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Cella</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Cleeland</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Dotan</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Eisenberger</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Escalante</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cancer-Related Fatigue, Version 2.2015</article-title>
                  <source>J. Natl. Compr. Cancer Netw.</source>
                  <year>2015</year>
                  <volume>13</volume>
                  <fpage>1012</fpage>
                  <lpage>1039</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2015.0122</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-curroncol-29-00658">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barton</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Journey to Oz in Search of a Remedy for Fatigue</article-title>
                  <source>Cancer J</source>
                  <year>2014</year>
                  <volume>20</volume>
                  <fpage>15</fpage>
                  <lpage>17</lpage>
                  <pub-id pub-id-type="doi">10.1097/PPO.0000000000000019</pub-id>
                  <pub-id pub-id-type="pmid">24445758</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-curroncol-29-00658">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Escalante</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <name>
                      <surname>Meyers</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Reuben</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Qiao</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Manzullo</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Alvarez</surname>
                      <given-names>R.H.</given-names>
                    </name>
                    <name>
                      <surname>Morrow</surname>
                      <given-names>P.K.</given-names>
                    </name>
                    <name>
                      <surname>Gonzalez-Angulo</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A Randomized, Double-Blind, 2-Period, Placebo-Controlled Crossover Trial of a Sustained-Release Methylphenidate in the Treatment of Fatigue in Cancer Patients</article-title>
                  <source>Cancer J.</source>
                  <year>2014</year>
                  <volume>20</volume>
                  <fpage>8</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="doi">10.1097/PPO.0000000000000018</pub-id>
                  <pub-id pub-id-type="pmid">24445757</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-curroncol-29-00658">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hovey</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>de Souza</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Marx</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Parente</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Rapke</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hill</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Bonaventura</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Michele</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Craft</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Abdi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Modafinil for Fatigue in Patients Treated with Docetaxel-Based Chemotherapy</article-title>
                  <source>Support. Care Cancer</source>
                  <year>2014</year>
                  <volume>22</volume>
                  <fpage>1233</fpage>
                  <lpage>1242</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00520-013-2076-0</pub-id>
                  <pub-id pub-id-type="pmid">24337761</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-curroncol-29-00658">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Auret</surname>
                      <given-names>K.A.</given-names>
                    </name>
                    <name>
                      <surname>Schug</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Bremner</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Bulsara</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Impact of Dexamphetamine on Fatigue in Patients with Advanced Cancer</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2009</year>
                  <volume>37</volume>
                  <fpage>613</fpage>
                  <lpage>621</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2008.03.016</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-curroncol-29-00658">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bruera</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Valero</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Driver</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Willey</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Palmer</surname>
                      <given-names>J.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Patient-Controlled Methylphenidate for Cancer Fatigue: A Double-Blind, Randomized, Placebo-Controlled Trial</article-title>
                  <source>J. Clin. Oncol.</source>
                  <year>2006</year>
                  <volume>24</volume>
                  <fpage>2073</fpage>
                  <lpage>2078</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2005.02.8506</pub-id>
                  <pub-id pub-id-type="pmid">16648508</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-curroncol-29-00658">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bruera</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Yennurajalingam</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Palmer</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Perez-Cruz</surname>
                      <given-names>P.E.</given-names>
                    </name>
                    <name>
                      <surname>Frisbee-Hume</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Allo</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>M.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Methylphenidate and/or a Nursing Telephone Intervention for Fatigue in Patients with Advanced Cancer: A Randomized, Placebo-Controlled, Phase II Trial</article-title>
                  <source>J. Clin. Oncol.</source>
                  <year>2013</year>
                  <volume>31</volume>
                  <fpage>2421</fpage>
                  <lpage>2427</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2012.45.3696</pub-id>
                  <pub-id pub-id-type="pmid">23690414</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-curroncol-29-00658">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Butler</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Case</surname>
                      <given-names>L.D.</given-names>
                    </name>
                    <name>
                      <surname>Atkins</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Frizzell</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Sanders</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Griffin</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Lesser</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>McMullen</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>McQuellon</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Naughton</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial of d-Threo-Methylphenidate HCl in Brain Tumor Patients Receiving Radiation Therapy</article-title>
                  <source>Int. J. Radiat. Oncol. Biol. Phys.</source>
                  <year>2007</year>
                  <volume>69</volume>
                  <fpage>1496</fpage>
                  <lpage>1501</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ijrobp.2007.05.076</pub-id>
                  <pub-id pub-id-type="pmid">17869448</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-curroncol-29-00658">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kerr</surname>
                      <given-names>C.W.</given-names>
                    </name>
                    <name>
                      <surname>Drake</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Milch</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Brazeau</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Skretny</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Brazeau</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Donnelly</surname>
                      <given-names>J.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Methylphenidate on Fatigue and Depression: A Randomized, Double-Blind, Placebo-Controlled Trial</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2012</year>
                  <volume>43</volume>
                  <fpage>68</fpage>
                  <lpage>77</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2011.03.026</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-curroncol-29-00658">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lower</surname>
                      <given-names>E.E.</given-names>
                    </name>
                    <name>
                      <surname>Fleishman</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Zeldis</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Faleck</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Manning</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of Dexmethylphenidate for the Treatment of Fatigue after Cancer Chemotherapy: A Randomized Clinical Trial</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2009</year>
                  <volume>38</volume>
                  <fpage>650</fpage>
                  <lpage>662</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2009.03.011</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-curroncol-29-00658">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mar Fan</surname>
                      <given-names>H.G.</given-names>
                    </name>
                    <name>
                      <surname>Clemons</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Chemerynsky</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Breunis</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Braganza</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Tannock</surname>
                      <given-names>I.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Randomised, Placebo-Controlled, Double-Blind Trial of the Effects of d-Methylphenidate on Fatigue and Cognitive Dysfunction in Women Undergoing Adjuvant Chemotherapy for Breast Cancer</article-title>
                  <source>Support. Care Cancer</source>
                  <year>2008</year>
                  <volume>16</volume>
                  <fpage>577</fpage>
                  <lpage>583</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00520-007-0341-9</pub-id>
                  <pub-id pub-id-type="pmid">17972110</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-curroncol-29-00658">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moraska</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Sood</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Dakhil</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Sloan</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Barton</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Atherton</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Suh</surname>
                      <given-names>J.J.</given-names>
                    </name>
                    <name>
                      <surname>Griffin</surname>
                      <given-names>P.C.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial</article-title>
                  <source>J. Clin. Oncol.</source>
                  <year>2010</year>
                  <volume>28</volume>
                  <fpage>3673</fpage>
                  <lpage>3679</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2010.28.1444</pub-id>
                  <pub-id pub-id-type="pmid">20625123</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-curroncol-29-00658">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Roth</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Nelson</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Rosenfeld</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Scher</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Slovin</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>O’Shea</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Arauz</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Breitbart</surname>
                      <given-names>W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Methylphenidate for Fatigue in Ambulatory Men with Prostate Cancer</article-title>
                  <source>Cancer</source>
                  <year>2010</year>
                  <volume>116</volume>
                  <fpage>5102</fpage>
                  <lpage>5110</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.25424</pub-id>
                  <pub-id pub-id-type="pmid">20665492</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-curroncol-29-00658">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Paulsen</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Klepstad</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Rosland</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Aass</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Albert</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Fayers</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Kaasa</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients with Advanced Cancer Using Opioids: A Randomized, Placebo-Controlled, Double-Blind Trial</article-title>
                  <source>J. Clin. Oncol.</source>
                  <year>2014</year>
                  <volume>32</volume>
                  <fpage>3221</fpage>
                  <lpage>3228</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2013.54.3926</pub-id>
                  <pub-id pub-id-type="pmid">25002731</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-curroncol-29-00658">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yennurajalingam</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Bruera</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Role of Corticosteroids for Fatigue in Advanced Incurable Cancer: Is It a “wonder Drug” or “Deal with the Devil”</article-title>
                  <source>Curr. Opin. Support Palliat. Care</source>
                  <year>2014</year>
                  <volume>8</volume>
                  <fpage>346</fpage>
                  <lpage>351</lpage>
                  <pub-id pub-id-type="doi">10.1097/SPC.0000000000000093</pub-id>
                  <pub-id pub-id-type="pmid">25259545</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-curroncol-29-00658">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Andrews</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Walker</surname>
                      <given-names>B.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Glucocorticoids and Insulin Resistance: Old Hormones, New Targets</article-title>
                  <source>Clin. Sci.</source>
                  <year>1999</year>
                  <volume>96</volume>
                  <fpage>513</fpage>
                  <lpage>523</lpage>
                  <pub-id pub-id-type="doi">10.1042/CS19980388</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-curroncol-29-00658">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Björntorp</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Rosmond</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Obesity and Cortisol</article-title>
                  <source>Nutrition</source>
                  <year>2000</year>
                  <volume>16</volume>
                  <fpage>924</fpage>
                  <lpage>936</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0899-9007(00)00422-6</pub-id>
                  <pub-id pub-id-type="pmid">11054598</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-curroncol-29-00658">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Darmon</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Dadoun</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Boullu-Ciocca</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Grino</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Alessi</surname>
                      <given-names>M.-C.</given-names>
                    </name>
                    <name>
                      <surname>Dutour</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Insulin Resistance Induced by Hydrocortisone Is Increased in Patients with Abdominal Obesity</article-title>
                  <source>Am. J. Physiol. Endocrinol. Metab.</source>
                  <year>2006</year>
                  <volume>291</volume>
                  <fpage>E995</fpage>
                  <lpage>E1002</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpendo.00654.2005</pub-id>
                  <pub-id pub-id-type="pmid">16772320</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-curroncol-29-00658">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bodine</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Furlow</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Glucocorticoids and Skeletal Muscle</article-title>
                  <source>Adv. Exp. Med. Biol.</source>
                  <year>2015</year>
                  <volume>872</volume>
                  <fpage>145</fpage>
                  <lpage>176</lpage>
                  <pub-id pub-id-type="pmid">26215994</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-curroncol-29-00658">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patil</surname>
                      <given-names>C.G.</given-names>
                    </name>
                    <name>
                      <surname>Lad</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>Katznelson</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Laws</surname>
                      <given-names>E.R.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                  </person-group>
                  <article-title>Brain Atrophy and Cognitive Deficits in Cushing’s Disease</article-title>
                  <source>Neurosurg. Focus</source>
                  <year>2007</year>
                  <volume>23</volume>
                  <fpage>E11</fpage>
                  <pub-id pub-id-type="doi">10.3171/foc.2007.23.3.13</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-curroncol-29-00658">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sapolsky</surname>
                      <given-names>R.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders</article-title>
                  <source>Arch. Gen. Psychiatry</source>
                  <year>2000</year>
                  <volume>57</volume>
                  <fpage>925</fpage>
                  <lpage>935</lpage>
                  <pub-id pub-id-type="doi">10.1001/archpsyc.57.10.925</pub-id>
                  <pub-id pub-id-type="pmid">11015810</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-curroncol-29-00658">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Alt</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Gore</surname>
                      <given-names>E.M.</given-names>
                    </name>
                    <name>
                      <surname>Montagnini</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>A.V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Muscle Endurance, Cancer-Related Fatigue, and Radiotherapy in Prostate Cancer Survivors</article-title>
                  <source>Muscle Nerve</source>
                  <year>2011</year>
                  <volume>43</volume>
                  <fpage>415</fpage>
                  <lpage>424</lpage>
                  <pub-id pub-id-type="doi">10.1002/mus.21913</pub-id>
                  <pub-id pub-id-type="pmid">21305569</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-curroncol-29-00658">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arnold</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Taylor</surname>
                      <given-names>N.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise for Patients with Cancer: Reducing Disease-Related Fatigue</article-title>
                  <source>Future Oncol.</source>
                  <year>2011</year>
                  <volume>7</volume>
                  <fpage>165</fpage>
                  <lpage>167</lpage>
                  <pub-id pub-id-type="doi">10.2217/fon.10.188</pub-id>
                  <pub-id pub-id-type="pmid">21345135</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-curroncol-29-00658">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McNeely</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Courneya</surname>
                      <given-names>K.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise Programs for Cancer-Related Fatigue: Evidence and Clinical Guidelines</article-title>
                  <source>J. Natl. Compr. Cancer Netw.</source>
                  <year>2010</year>
                  <volume>8</volume>
                  <fpage>945</fpage>
                  <lpage>953</lpage>
                  <pub-id pub-id-type="doi">10.6004/jnccn.2010.0069</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-curroncol-29-00658">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schmitz</surname>
                      <given-names>K.H.</given-names>
                    </name>
                    <name>
                      <surname>Courneya</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Matthews</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Demark-Wahnefried</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Galvão</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Pinto</surname>
                      <given-names>B.M.</given-names>
                    </name>
                    <name>
                      <surname>Irwin</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Wolin</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Segal</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Lucia</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors</article-title>
                  <source>Med. Sci. Sports Exerc.</source>
                  <year>2010</year>
                  <volume>42</volume>
                  <fpage>1409</fpage>
                  <lpage>1426</lpage>
                  <pub-id pub-id-type="doi">10.1249/MSS.0b013e3181e0c112</pub-id>
                  <pub-id pub-id-type="pmid">20559064</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-curroncol-29-00658">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Weert</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>May</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Korstjens</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Post</surname>
                      <given-names>W.J.</given-names>
                    </name>
                    <name>
                      <surname>van der Schans</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <name>
                      <surname>van den Borne</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Mesters</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Ros</surname>
                      <given-names>W.J.</given-names>
                    </name>
                    <name>
                      <surname>Hoekstra-Weebers</surname>
                      <given-names>J.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer-Related Fatigue and Rehabilitation: A Randomized Controlled Multicenter Trial Comparing Physical Training Combined with Cognitive-Behavioral Therapy with Physical Training Only and with no Intervention</article-title>
                  <source>Phys. Rev. D Part. Fields</source>
                  <year>2010</year>
                  <volume>90</volume>
                  <fpage>1413</fpage>
                  <lpage>1425</lpage>
                </element-citation>
              </ref>
              <ref id="B45-curroncol-29-00658">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brown</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Huedo-Medina</surname>
                      <given-names>T.B.</given-names>
                    </name>
                    <name>
                      <surname>Pescatello</surname>
                      <given-names>L.S.</given-names>
                    </name>
                    <name>
                      <surname>Pescatello</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Ferrer</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Johnson</surname>
                      <given-names>B.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Efficacy of Exercise Interventions in Modulating Cancer-Related Fatigue among Adult Cancer Survivors: A Meta-Analysis</article-title>
                  <source>Cancer Epidemiol. Biomark. Prev.</source>
                  <year>2011</year>
                  <volume>20</volume>
                  <fpage>123</fpage>
                  <lpage>133</lpage>
                  <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-10-0988</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-curroncol-29-00658">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>George</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Alfano</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Neuhouser</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>A.W.</given-names>
                    </name>
                    <name>
                      <surname>Baumgartner</surname>
                      <given-names>R.N.</given-names>
                    </name>
                    <name>
                      <surname>Baumgartner</surname>
                      <given-names>K.B.</given-names>
                    </name>
                    <name>
                      <surname>Bernstein</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Ballard-Barbash</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Better Postdiagnosis Diet Quality Is Associated with Less Cancer-Related Fatigue in Breast Cancer Survivors</article-title>
                  <source>J. Cancer Surviv.</source>
                  <year>2014</year>
                  <volume>8</volume>
                  <fpage>680</fpage>
                  <lpage>687</lpage>
                  <pub-id pub-id-type="doi">10.1007/s11764-014-0381-3</pub-id>
                  <pub-id pub-id-type="pmid">25001403</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-curroncol-29-00658">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maskarinec</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Hullar</surname>
                      <given-names>M.A.J.</given-names>
                    </name>
                    <name>
                      <surname>Monroe</surname>
                      <given-names>K.R.</given-names>
                    </name>
                    <name>
                      <surname>Shepherd</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Hunt</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Randolph</surname>
                      <given-names>T.W.</given-names>
                    </name>
                    <name>
                      <surname>Wilkens</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>Boushey</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Le Marchand</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>U.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Fecal Microbial Diversity and Structure Are Associated with Diet Quality in the Multiethnic Cohort Adiposity Phenotype Study</article-title>
                  <source>J. Nutr.</source>
                  <year>2019</year>
                  <volume>149</volume>
                  <fpage>1575</fpage>
                  <lpage>1584</lpage>
                  <pub-id pub-id-type="doi">10.1093/jn/nxz065</pub-id>
                  <pub-id pub-id-type="pmid">31187868</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-curroncol-29-00658">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ma</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Maskarinec</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>U.</given-names>
                    </name>
                    <name>
                      <surname>Boushey</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Wilkens</surname>
                      <given-names>L.R.</given-names>
                    </name>
                    <name>
                      <surname>Setiawan</surname>
                      <given-names>V.W.</given-names>
                    </name>
                    <name>
                      <surname>Le Marchand</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Randolph</surname>
                      <given-names>T.W.</given-names>
                    </name>
                    <name>
                      <surname>Jenkins</surname>
                      <given-names>I.C.</given-names>
                    </name>
                    <name>
                      <surname>Curtis</surname>
                      <given-names>K.R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Long-Term Association between Diet Quality and Characteristics of the Gut Microbiome in the Multiethnic Cohort Study</article-title>
                  <source>Br. J. Nutr</source>
                  <year>2021</year>
                  <volume>128</volume>
                  <fpage>93</fpage>
                  <lpage>102</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0007114521002968</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-curroncol-29-00658">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chan</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Shwe</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Koh</surname>
                      <given-names>S.A.Q.</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chan</surname>
                      <given-names>Y.S.</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Ang</surname>
                      <given-names>X.J.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>W.Q.</given-names>
                    </name>
                    <name>
                      <surname>Khine</surname>
                      <given-names>W.W.T.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>Y.K.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gut Microbiome Alterations in Breast Cancer Survivors with Cancer-Related Fatigue</article-title>
                  <source>J. Clin. Orthod.</source>
                  <year>2018</year>
                  <volume>36</volume>
                  <fpage>e22178</fpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2018.36.15_suppl.e22178</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-curroncol-29-00658">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiao</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Fedirko</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Beitler</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bai</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Peng</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>I.-H.</given-names>
                    </name>
                    <name>
                      <surname>Chico</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Role of the Gut Microbiome in Cancer-Related Fatigue: Pilot Study on Epigenetic Mechanisms</article-title>
                  <source>Support. Care Cancer</source>
                  <year>2021</year>
                  <volume>29</volume>
                  <fpage>3173</fpage>
                  <lpage>3182</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00520-020-05820-3</pub-id>
                  <pub-id pub-id-type="pmid">33078326</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-curroncol-29-00658">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Topkan</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Yavuz</surname>
                      <given-names>A.A.</given-names>
                    </name>
                    <name>
                      <surname>Ozyilkan</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer Cachexia: Pathophysiologic Aspects and Treatment Options</article-title>
                  <source>Asian Pac. J. Cancer Prev.</source>
                  <year>2007</year>
                  <volume>8</volume>
                  <fpage>445</fpage>
                  <lpage>451</lpage>
                  <pub-id pub-id-type="pmid">18159985</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-curroncol-29-00658">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fearon</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Strasser</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Anker</surname>
                      <given-names>S.D.</given-names>
                    </name>
                    <name>
                      <surname>Bosaeus</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Bruera</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Fainsinger</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Jatoi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Loprinzi</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>MacDonald</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Mantovani</surname>
                      <given-names>G.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Definition and Classification of Cancer Cachexia: An International Consensus</article-title>
                  <source>Lancet Oncol.</source>
                  <year>2011</year>
                  <volume>12</volume>
                  <fpage>489</fpage>
                  <lpage>495</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1470-2045(10)70218-7</pub-id>
                  <pub-id pub-id-type="pmid">21296615</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-curroncol-29-00658">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jeejeebhoy</surname>
                      <given-names>K.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Malnutrition, Fatigue, Frailty, Vulnerability, Sarcopenia and Cachexia: Overlap of Clinical Features</article-title>
                  <source>Curr. Opin. Clin. Nutr. Metab. Care</source>
                  <year>2012</year>
                  <volume>15</volume>
                  <fpage>213</fpage>
                  <lpage>219</lpage>
                  <pub-id pub-id-type="doi">10.1097/MCO.0b013e328352694f</pub-id>
                  <pub-id pub-id-type="pmid">22450775</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-curroncol-29-00658">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wright</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Dillon</surname>
                      <given-names>E.L.</given-names>
                    </name>
                    <name>
                      <surname>Durham</surname>
                      <given-names>W.J.</given-names>
                    </name>
                    <name>
                      <surname>Chamberlain</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Randolph</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Danesi</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Horstman</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Gilkison</surname>
                      <given-names>C.R.</given-names>
                    </name>
                    <name>
                      <surname>Willis</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Richardson</surname>
                      <given-names>G.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A Randomized Trial of Adjunct Testosterone for Cancer-Related Muscle Loss in Men and Women</article-title>
                  <source>J. Cachexia Sarcopenia Muscle</source>
                  <year>2018</year>
                  <volume>9</volume>
                  <fpage>482</fpage>
                  <lpage>496</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcsm.12295</pub-id>
                  <pub-id pub-id-type="pmid">29654645</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-curroncol-29-00658">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bianchi</surname>
                      <given-names>V.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Anti-Inflammatory Effects of Testosterone</article-title>
                  <source>J. Endocr. Soc.</source>
                  <year>2019</year>
                  <volume>3</volume>
                  <fpage>91</fpage>
                  <lpage>107</lpage>
                  <pub-id pub-id-type="doi">10.1210/js.2018-00186</pub-id>
                  <pub-id pub-id-type="pmid">30582096</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-curroncol-29-00658">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Malkin</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Pugh</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>R.D.</given-names>
                    </name>
                    <name>
                      <surname>Kapoor</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Channer</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>T.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2004</year>
                  <volume>89</volume>
                  <fpage>3313</fpage>
                  <lpage>3318</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2003-031069</pub-id>
                  <pub-id pub-id-type="pmid">15240608</pub-id>
                </element-citation>
              </ref>
              <ref id="B57-curroncol-29-00658">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kalinchenko</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                    <name>
                      <surname>Tishova</surname>
                      <given-names>Y.A.</given-names>
                    </name>
                    <name>
                      <surname>Mskhalaya</surname>
                      <given-names>G.J.</given-names>
                    </name>
                    <name>
                      <surname>Gooren</surname>
                      <given-names>L.J.G.</given-names>
                    </name>
                    <name>
                      <surname>Giltay</surname>
                      <given-names>E.J.</given-names>
                    </name>
                    <name>
                      <surname>Saad</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Testosterone Supplementation on Markers of the Metabolic Syndrome and Inflammation in Hypogonadal Men with the Metabolic Syndrome: The Double-Blinded Placebo-Controlled Moscow Study</article-title>
                  <source>Clin. Endocrinol.</source>
                  <year>2010</year>
                  <volume>73</volume>
                  <fpage>602</fpage>
                  <lpage>612</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1365-2265.2010.03845.x</pub-id>
                </element-citation>
              </ref>
              <ref id="B58-curroncol-29-00658">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dhindsa</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ghanim</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Batra</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kuhadiya</surname>
                      <given-names>N.D.</given-names>
                    </name>
                    <name>
                      <surname>Abuaysheh</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sandhu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Makdissi</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Hejna</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Chaudhuri</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction after Testosterone Replacement in Men with Type 2 Diabetes</article-title>
                  <source>Diabetes Care</source>
                  <year>2016</year>
                  <volume>39</volume>
                  <fpage>82</fpage>
                  <lpage>91</lpage>
                  <pub-id pub-id-type="doi">10.2337/dc15-1518</pub-id>
                  <pub-id pub-id-type="pmid">26622051</pub-id>
                </element-citation>
              </ref>
              <ref id="B59-curroncol-29-00658">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Baracos</surname>
                      <given-names>V.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Management of Muscle Wasting in Cancer-Associated Cachexia: Understanding Gained from Experimental Studies</article-title>
                  <source>Cancer</source>
                  <year>2001</year>
                  <volume>92</volume>
                  <fpage>1669</fpage>
                  <lpage>1677</lpage>
                  <pub-id pub-id-type="doi">10.1002/1097-0142(20010915)92:6+&lt;1669::AID-CNCR1495&gt;3.0.CO;2-S</pub-id>
                  <pub-id pub-id-type="pmid">11598885</pub-id>
                </element-citation>
              </ref>
              <ref id="B60-curroncol-29-00658">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stein</surname>
                      <given-names>K.D.</given-names>
                    </name>
                    <name>
                      <surname>Martin</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Hann</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Jacobsen</surname>
                      <given-names>P.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Multidimensional Measure of Fatigue for Use with Cancer Patients</article-title>
                  <source>Cancer Pract.</source>
                  <year>1998</year>
                  <volume>6</volume>
                  <fpage>143</fpage>
                  <lpage>152</lpage>
                  <pub-id pub-id-type="doi">10.1046/j.1523-5394.1998.006003143.x</pub-id>
                  <pub-id pub-id-type="pmid">9652245</pub-id>
                </element-citation>
              </ref>
              <ref id="B61-curroncol-29-00658">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chan</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Yo</surname>
                      <given-names>T.E.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.J.</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Chae</surname>
                      <given-names>J.-W.</given-names>
                    </name>
                    <name>
                      <surname>Yeo</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Shwe</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gan</surname>
                      <given-names>Y.X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Minimal Clinically Important Difference of the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) for Fatigue Worsening in Asian Breast Cancer Patients</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2018</year>
                  <volume>55</volume>
                  <fpage>992</fpage>
                  <lpage>997.e2</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2017.10.014</pub-id>
                </element-citation>
              </ref>
              <ref id="B62-curroncol-29-00658">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cordero</surname>
                      <given-names>E.D.</given-names>
                    </name>
                    <name>
                      <surname>Loredo</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Murray</surname>
                      <given-names>K.E.</given-names>
                    </name>
                    <name>
                      <surname>Dimsdale</surname>
                      <given-names>J.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Characterizing Fatigue: The Effects of Ethnicity and Acculturation</article-title>
                  <source>J. Appl. Biobehav. Res.</source>
                  <year>2012</year>
                  <volume>17</volume>
                  <fpage>59</fpage>
                  <lpage>78</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1751-9861.2012.00077.x</pub-id>
                  <pub-id pub-id-type="pmid">22773899</pub-id>
                </element-citation>
              </ref>
              <ref id="B63-curroncol-29-00658">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Asvat</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Malcarne</surname>
                      <given-names>V.L.</given-names>
                    </name>
                    <name>
                      <surname>Sadler</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Jacobsen</surname>
                      <given-names>P.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Validity of the Multidimensional Fatigue Symptom Inventory-Short Form in an African-American Community-Based Sample</article-title>
                  <source>Ethn. Health</source>
                  <year>2014</year>
                  <volume>19</volume>
                  <fpage>631</fpage>
                  <lpage>644</lpage>
                  <pub-id pub-id-type="doi">10.1080/13557858.2014.885933</pub-id>
                  <pub-id pub-id-type="pmid">24527980</pub-id>
                </element-citation>
              </ref>
              <ref id="B64-curroncol-29-00658">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Curran</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Andrykowski</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Studts</surname>
                      <given-names>J.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Short Form of the Profile of Mood States (POMS-SF): Psychometric Information</article-title>
                  <source>Psychol. Assess.</source>
                  <year>1995</year>
                  <volume>7</volume>
                  <fpage>80</fpage>
                  <lpage>83</lpage>
                  <pub-id pub-id-type="doi">10.1037/1040-3590.7.1.80</pub-id>
                </element-citation>
              </ref>
              <ref id="B65-curroncol-29-00658">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nyenhuis</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Yamamoto</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Luchetta</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Terrien</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Parmentier</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Adult and Geriatric Normative Data and Validation of the Profile of Mood States</article-title>
                  <source>J. Clin. Psychol.</source>
                  <year>1999</year>
                  <volume>55</volume>
                  <fpage>79</fpage>
                  <lpage>86</lpage>
                  <pub-id pub-id-type="doi">10.1002/(SICI)1097-4679(199901)55:1&lt;79::AID-JCLP8&gt;3.0.CO;2-7</pub-id>
                  <pub-id pub-id-type="pmid">10100834</pub-id>
                </element-citation>
              </ref>
              <ref id="B66-curroncol-29-00658">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hays</surname>
                      <given-names>R.D.</given-names>
                    </name>
                    <name>
                      <surname>Sherbourne</surname>
                      <given-names>C.D.</given-names>
                    </name>
                    <name>
                      <surname>Mazel</surname>
                      <given-names>R.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>The RAND 36-Item Health Survey 1.0</article-title>
                  <source>Health Econ.</source>
                  <year>1993</year>
                  <volume>2</volume>
                  <fpage>217</fpage>
                  <lpage>227</lpage>
                  <pub-id pub-id-type="doi">10.1002/hec.4730020305</pub-id>
                  <pub-id pub-id-type="pmid">8275167</pub-id>
                </element-citation>
              </ref>
              <ref id="B67-curroncol-29-00658">
                <label>67.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ware</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Snow</surname>
                      <given-names>K.K.</given-names>
                    </name>
                    <name>
                      <surname>Kosinski</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gandek</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <source>SF-36 Health Survey: Manual and Interpretation Guide</source>
                  <publisher-name>The Health Institute</publisher-name>
                  <publisher-loc>Scarborough, ON, Canada</publisher-loc>
                  <year>1993</year>
                </element-citation>
              </ref>
              <ref id="B68-curroncol-29-00658">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ringash</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bezjak</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>O’Sullivan</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Redelmeier</surname>
                      <given-names>D.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interpreting Differences in Quality of Life: The FACT-H&amp;N in Laryngeal Cancer Patients</article-title>
                  <source>Qual. Life Res.</source>
                  <year>2004</year>
                  <volume>13</volume>
                  <fpage>725</fpage>
                  <lpage>733</lpage>
                  <pub-id pub-id-type="pmid">15129883</pub-id>
                </element-citation>
              </ref>
              <ref id="B69-curroncol-29-00658">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hornsby</surname>
                      <given-names>B.W.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kipp</surname>
                      <given-names>A.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Subjective Ratings of Fatigue and Vigor in Adults with Hearing Loss Are Driven by Perceived Hearing Difficulties Not Degree of Hearing Loss</article-title>
                  <source>Ear Hear.</source>
                  <year>2016</year>
                  <volume>37</volume>
                  <fpage>e1</fpage>
                  <lpage>e10</lpage>
                  <pub-id pub-id-type="doi">10.1097/AUD.0000000000000203</pub-id>
                  <pub-id pub-id-type="pmid">26295606</pub-id>
                </element-citation>
              </ref>
              <ref id="B70-curroncol-29-00658">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yavuzsen</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Ranganathan</surname>
                      <given-names>V.K.</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Siemionow</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Kirkova</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Khoshknabi</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Lagman</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>LeGrand</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Yue</surname>
                      <given-names>G.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer-Related Fatigue: Central or Peripheral?</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2009</year>
                  <volume>38</volume>
                  <fpage>587</fpage>
                  <lpage>596</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2008.12.003</pub-id>
                </element-citation>
              </ref>
              <ref id="B71-curroncol-29-00658">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Davis</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms of Fatigue</article-title>
                  <source>J. Support. Oncol.</source>
                  <year>2010</year>
                  <volume>8</volume>
                  <fpage>164</fpage>
                  <lpage>174</lpage>
                  <pub-id pub-id-type="pmid">20822034</pub-id>
                </element-citation>
              </ref>
              <ref id="B72-curroncol-29-00658">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taylor</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Todd</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Gandevia</surname>
                      <given-names>S.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evidence for a Supraspinal Contribution to Human Muscle Fatigue</article-title>
                  <source>Clin. Exp. Pharmacol. Physiol.</source>
                  <year>2006</year>
                  <volume>33</volume>
                  <fpage>400</fpage>
                  <lpage>405</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1440-1681.2006.04363.x</pub-id>
                  <pub-id pub-id-type="pmid">16620309</pub-id>
                </element-citation>
              </ref>
              <ref id="B73-curroncol-29-00658">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Taylor</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Gandevia</surname>
                      <given-names>S.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Comparison of Central Aspects of Fatigue in Submaximal and Maximal Voluntary Contractions</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2008</year>
                  <volume>104</volume>
                  <fpage>542</fpage>
                  <lpage>550</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.01053.2007</pub-id>
                  <pub-id pub-id-type="pmid">18032577</pub-id>
                </element-citation>
              </ref>
              <ref id="B74-curroncol-29-00658">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bigland-Ritchie</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Hosking</surname>
                      <given-names>G.P.</given-names>
                    </name>
                    <name>
                      <surname>Edwards</surname>
                      <given-names>R.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Central and Peripheral Fatigue in Sustained Maximum Voluntary Contractions of Human Quadriceps Muscle</article-title>
                  <source>Clin. Sci. Mol. Med.</source>
                  <year>1978</year>
                  <volume>54</volume>
                  <fpage>609</fpage>
                  <lpage>614</lpage>
                  <pub-id pub-id-type="doi">10.1042/cs0540609</pub-id>
                  <pub-id pub-id-type="pmid">657729</pub-id>
                </element-citation>
              </ref>
              <ref id="B75-curroncol-29-00658">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chaudhuri</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Behan</surname>
                      <given-names>P.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fatigue in Neurological Disorders</article-title>
                  <source>Lancet</source>
                  <year>2004</year>
                  <volume>363</volume>
                  <fpage>978</fpage>
                  <lpage>988</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(04)15794-2</pub-id>
                  <pub-id pub-id-type="pmid">15043967</pub-id>
                </element-citation>
              </ref>
              <ref id="B76-curroncol-29-00658">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chaudhuri</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Behan</surname>
                      <given-names>P.O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fatigue and Basal Ganglia</article-title>
                  <source>J. Neurol. Sci.</source>
                  <year>2000</year>
                  <volume>179</volume>
                  <fpage>34</fpage>
                  <lpage>42</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0022-510X(00)00411-1</pub-id>
                  <pub-id pub-id-type="pmid">11054483</pub-id>
                </element-citation>
              </ref>
              <ref id="B77-curroncol-29-00658">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fernandez</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Firdous</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Jehangir</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Behm</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Berger</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Davis</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer-Related Fatigue: Perception of Effort or Task Failure?</article-title>
                  <source>Am. J. Hosp. Palliat. Care</source>
                  <year>2020</year>
                  <volume>37</volume>
                  <fpage>34</fpage>
                  <lpage>40</lpage>
                  <pub-id pub-id-type="doi">10.1177/1049909119849420</pub-id>
                  <pub-id pub-id-type="pmid">31084200</pub-id>
                </element-citation>
              </ref>
              <ref id="B78-curroncol-29-00658">
                <label>78.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kozłowski</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Zakrzewska</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Tokajuk</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Wojtukiewicz</surname>
                      <given-names>M.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Concentration of Interleukin-6 (IL-6), Interleukin-8 (IL-8) and Interleukin-10 (IL-10) in Blood Serum of Breast Cancer Patients</article-title>
                  <source>Rocz. Akad. Med. Bialymst.</source>
                  <year>2003</year>
                  <volume>48</volume>
                  <fpage>82</fpage>
                  <lpage>84</lpage>
                  <pub-id pub-id-type="pmid">14737948</pub-id>
                </element-citation>
              </ref>
              <ref id="B79-curroncol-29-00658">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Adler</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>McCURDY</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Kattan</surname>
                      <given-names>M.W.</given-names>
                    </name>
                    <name>
                      <surname>Timme</surname>
                      <given-names>T.L.</given-names>
                    </name>
                    <name>
                      <surname>Scardino</surname>
                      <given-names>P.T.</given-names>
                    </name>
                    <name>
                      <surname>Thompson</surname>
                      <given-names>T.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Elevated Levels of Circulating Interleukin-6 and Transforming Growth Factor-Beta1 in Patients with Metastatic Prostatic Carcinoma</article-title>
                  <source>J. Urol.</source>
                  <year>1999</year>
                  <volume>161</volume>
                  <fpage>182</fpage>
                  <lpage>187</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0022-5347(01)62092-5</pub-id>
                  <pub-id pub-id-type="pmid">10037394</pub-id>
                </element-citation>
              </ref>
              <ref id="B80-curroncol-29-00658">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Miura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Mitsunaga</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ikeda</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Shimizu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ohno</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Takahashi</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Furuse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Inagaki</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Higashi</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Kato</surname>
                      <given-names>H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Characterization of Patients with Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels</article-title>
                  <source>Pancreas</source>
                  <year>2015</year>
                  <volume>44</volume>
                  <fpage>756</fpage>
                  <lpage>763</lpage>
                  <pub-id pub-id-type="doi">10.1097/MPA.0000000000000335</pub-id>
                  <pub-id pub-id-type="pmid">25931255</pub-id>
                </element-citation>
              </ref>
              <ref id="B81-curroncol-29-00658">
                <label>81.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Knüpfer</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Preiss</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Significance of Interleukin-6 (IL-6) in Breast Cancer (Review)</article-title>
                  <source>Breast Cancer Res. Treat.</source>
                  <year>2007</year>
                  <volume>102</volume>
                  <fpage>129</fpage>
                  <lpage>135</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10549-006-9328-3</pub-id>
                  <pub-id pub-id-type="pmid">16927176</pub-id>
                </element-citation>
              </ref>
              <ref id="B82-curroncol-29-00658">
                <label>82.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bossola</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Di Stasio</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Giungi</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Rosa</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Tazza</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Fatigue Is Associated with Serum Interleukin-6 Levels and Symptoms of Depression in Patients on Chronic Hemodialysis</article-title>
                  <source>J. Pain Symptom Manag.</source>
                  <year>2015</year>
                  <volume>49</volume>
                  <fpage>578</fpage>
                  <lpage>585</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jpainsymman.2014.07.009</pub-id>
                </element-citation>
              </ref>
              <ref id="B83-curroncol-29-00658">
                <label>83.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pereira</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>L.V.D.</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>R.M.S.</given-names>
                    </name>
                    <name>
                      <surname>Campos</surname>
                      <given-names>A.L.F.</given-names>
                    </name>
                    <name>
                      <surname>Pimenta</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>de Oliveira</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Bacheti</surname>
                      <given-names>G.G.</given-names>
                    </name>
                    <name>
                      <surname>Rocha</surname>
                      <given-names>N.P.</given-names>
                    </name>
                    <name>
                      <surname>Teixeira</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Christo</surname>
                      <given-names>P.P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>IL-6 Serum Levels Are Elevated in Parkinson’s Disease Patients with Fatigue Compared to Patients without Fatigue</article-title>
                  <source>J. Neurol. Sci.</source>
                  <year>2016</year>
                  <volume>370</volume>
                  <fpage>153</fpage>
                  <lpage>156</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jns.2016.09.030</pub-id>
                  <pub-id pub-id-type="pmid">27772747</pub-id>
                </element-citation>
              </ref>
              <ref id="B84-curroncol-29-00658">
                <label>84.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Späth-Schwalbe</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Hansen</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Schrezenmeier</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Marshall</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Burger</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Fehm</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Born</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Acute Effects of Recombinant Human Interleukin-6 on Endocrine and Central Nervous Sleep Functions in Healthy Men</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>1998</year>
                  <volume>83</volume>
                  <fpage>1573</fpage>
                  <lpage>1579</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.83.5.1573</pub-id>
                  <pub-id pub-id-type="pmid">9589658</pub-id>
                </element-citation>
              </ref>
              <ref id="B85-curroncol-29-00658">
                <label>85.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bagnall-Moreau</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Chaudhry</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Salas-Ramirez</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Ahles</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hubbard</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus</article-title>
                  <source>Mol. Neurobiol.</source>
                  <year>2019</year>
                  <volume>56</volume>
                  <fpage>7159</fpage>
                  <lpage>7172</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12035-019-1589-z</pub-id>
                  <pub-id pub-id-type="pmid">30989632</pub-id>
                </element-citation>
              </ref>
              <ref id="B86-curroncol-29-00658">
                <label>86.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stasi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Abriani</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Beccaglia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Terzoli</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Amadori</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cancer-Related Fatigue: Evolving Concepts in Evaluation and Treatment</article-title>
                  <source>Cancer</source>
                  <year>2003</year>
                  <volume>98</volume>
                  <fpage>1786</fpage>
                  <lpage>1801</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.11742</pub-id>
                  <pub-id pub-id-type="pmid">14584059</pub-id>
                </element-citation>
              </ref>
              <ref id="B87-curroncol-29-00658">
                <label>87.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Singer</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Kuhnt</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Zwerenz</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Eckert</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Hofmeister</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Dietz</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Giesinger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hauss</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Papsdorf</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Briest</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Age- and Sex-Standardised Prevalence Rates of Fatigue in a Large Hospital-Based Sample of Cancer Patients</article-title>
                  <source>Br. J. Cancer</source>
                  <year>2011</year>
                  <volume>105</volume>
                  <fpage>445</fpage>
                  <lpage>451</lpage>
                  <pub-id pub-id-type="doi">10.1038/bjc.2011.251</pub-id>
                  <pub-id pub-id-type="pmid">21750551</pub-id>
                </element-citation>
              </ref>
              <ref id="B88-curroncol-29-00658">
                <label>88.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ganz</surname>
                      <given-names>P.A.</given-names>
                    </name>
                    <name>
                      <surname>Moinpour</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Pauler</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Kornblith</surname>
                      <given-names>A.B.</given-names>
                    </name>
                    <name>
                      <surname>Gaynor</surname>
                      <given-names>E.R.</given-names>
                    </name>
                    <name>
                      <surname>Balcerzak</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>Gatti</surname>
                      <given-names>G.S.</given-names>
                    </name>
                    <name>
                      <surname>Erba</surname>
                      <given-names>H.P.</given-names>
                    </name>
                    <name>
                      <surname>McCoy</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Press</surname>
                      <given-names>O.W.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Health Status and Quality of Life in Patients with Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133</article-title>
                  <source>J. Clin. Oncol.</source>
                  <year>2003</year>
                  <volume>21</volume>
                  <fpage>3512</fpage>
                  <lpage>3519</lpage>
                  <pub-id pub-id-type="doi">10.1200/JCO.2003.01.044</pub-id>
                  <pub-id pub-id-type="pmid">12972528</pub-id>
                </element-citation>
              </ref>
              <ref id="B89-curroncol-29-00658">
                <label>89.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hermelink</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Untch</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lux</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Kreienberg</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Beck</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Bauerfeind</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Münzel</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive Function during Neoadjuvant Chemotherapy for Breast Cancer: Results of a Prospective, Multicenter, Longitudinal Study</article-title>
                  <source>Cancer</source>
                  <year>2007</year>
                  <volume>109</volume>
                  <fpage>1905</fpage>
                  <lpage>1913</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.22610</pub-id>
                  <pub-id pub-id-type="pmid">17351951</pub-id>
                </element-citation>
              </ref>
              <ref id="B90-curroncol-29-00658">
                <label>90.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lange</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Giffard</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Noal</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Rigal</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Kurtz</surname>
                      <given-names>J.-E.</given-names>
                    </name>
                    <name>
                      <surname>Heutte</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lévy</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Allouache</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Rieux</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Le Fel</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Baseline Cognitive Functions among Elderly Patients with Localised Breast Cancer</article-title>
                  <source>Eur. J. Cancer</source>
                  <year>2014</year>
                  <volume>50</volume>
                  <fpage>2181</fpage>
                  <lpage>2189</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ejca.2014.05.026</pub-id>
                  <pub-id pub-id-type="pmid">24958735</pub-id>
                </element-citation>
              </ref>
              <ref id="B91-curroncol-29-00658">
                <label>91.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Menning</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>de Ruiter</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Veltman</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Koppelmans</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Kirschbaum</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Boogerd</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Reneman</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Schangen</surname>
                      <given-names>S.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Multimodal MRI and Cognitive Function in Patients with Breast Cancer Prior to Adjuvant Treatment—The Role of Fatigue</article-title>
                  <source>NeuroImage: Clinical</source>
                  <year>2015</year>
                  <volume>7</volume>
                  <fpage>547</fpage>
                  <lpage>554</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.nicl.2015.02.005</pub-id>
                  <pub-id pub-id-type="pmid">25844311</pub-id>
                </element-citation>
              </ref>
              <ref id="B92-curroncol-29-00658">
                <label>92.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bond</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Dietrich</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Murphy</surname>
                      <given-names>B.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Neurocognitive Function in Head and Neck Cancer Patients Prior to Treatment</article-title>
                  <source>Support. Care Cancer</source>
                  <year>2012</year>
                  <volume>20</volume>
                  <fpage>149</fpage>
                  <lpage>157</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00520-010-1081-9</pub-id>
                  <pub-id pub-id-type="pmid">21229270</pub-id>
                </element-citation>
              </ref>
              <ref id="B93-curroncol-29-00658">
                <label>93.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ahles</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Saykin</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>McDonald</surname>
                      <given-names>B.C.</given-names>
                    </name>
                    <name>
                      <surname>Furstenberg</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Cole</surname>
                      <given-names>B.F.</given-names>
                    </name>
                    <name>
                      <surname>Hanscom</surname>
                      <given-names>B.S.</given-names>
                    </name>
                    <name>
                      <surname>Mulrooney</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Schwartz</surname>
                      <given-names>G.N.</given-names>
                    </name>
                    <name>
                      <surname>Kaufman</surname>
                      <given-names>P.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive Function in Breast Cancer Patients Prior to Adjuvant Treatment</article-title>
                  <source>Breast Cancer Res. Treat.</source>
                  <year>2008</year>
                  <volume>110</volume>
                  <fpage>143</fpage>
                  <lpage>152</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10549-007-9686-5</pub-id>
                  <pub-id pub-id-type="pmid">17674194</pub-id>
                </element-citation>
              </ref>
              <ref id="B94-curroncol-29-00658">
                <label>94.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wefel</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Saleeba</surname>
                      <given-names>A.K.</given-names>
                    </name>
                    <name>
                      <surname>Buzdar</surname>
                      <given-names>A.U.</given-names>
                    </name>
                    <name>
                      <surname>Meyers</surname>
                      <given-names>C.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Acute and Late Onset Cognitive Dysfunction Associated with Chemotherapy in Women with Breast Cancer</article-title>
                  <source>Cancer</source>
                  <year>2010</year>
                  <volume>116</volume>
                  <fpage>3348</fpage>
                  <lpage>3356</lpage>
                  <pub-id pub-id-type="doi">10.1002/cncr.25098</pub-id>
                  <pub-id pub-id-type="pmid">20564075</pub-id>
                </element-citation>
              </ref>
              <ref id="B95-curroncol-29-00658">
                <label>95.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Long</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Cao</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Perceived Cognitive Impairment in Chinese Patients with Breast Cancer and Its Relationship with Post-Traumatic Stress Disorder Symptoms and Fatigue</article-title>
                  <source>Psychooncology</source>
                  <year>2015</year>
                  <volume>24</volume>
                  <fpage>676</fpage>
                  <lpage>682</lpage>
                  <pub-id pub-id-type="doi">10.1002/pon.3710</pub-id>
                  <pub-id pub-id-type="pmid">25345397</pub-id>
                </element-citation>
              </ref>
              <ref id="B96-curroncol-29-00658">
                <label>96.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Janelsins</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Kesler</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Ahles</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Morrow</surname>
                      <given-names>G.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence, Mechanisms, and Management of Cancer-Related Cognitive Impairment</article-title>
                  <source>Int. Rev. Psychiatry</source>
                  <year>2014</year>
                  <volume>26</volume>
                  <fpage>102</fpage>
                  <lpage>113</lpage>
                  <pub-id pub-id-type="doi">10.3109/09540261.2013.864260</pub-id>
                  <pub-id pub-id-type="pmid">24716504</pub-id>
                </element-citation>
              </ref>
              <ref id="B97-curroncol-29-00658">
                <label>97.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gibson</surname>
                      <given-names>E.M.</given-names>
                    </name>
                    <name>
                      <surname>Monje</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Microglia in Cancer Therapy-Related Cognitive Impairment</article-title>
                  <source>Trends Neurosci.</source>
                  <year>2021</year>
                  <volume>44</volume>
                  <fpage>441</fpage>
                  <lpage>451</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tins.2021.02.003</pub-id>
                  <pub-id pub-id-type="pmid">33674135</pub-id>
                </element-citation>
              </ref>
              <ref id="B98-curroncol-29-00658">
                <label>98.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Briones</surname>
                      <given-names>T.L.</given-names>
                    </name>
                    <name>
                      <surname>Woods</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dysregulation in Myelination Mediated by Persistent Neuroinflammation: Possible Mechanisms in Chemotherapy-Related Cognitive Impairment</article-title>
                  <source>Brain Behav. Immun.</source>
                  <year>2014</year>
                  <volume>35</volume>
                  <fpage>23</fpage>
                  <lpage>32</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbi.2013.07.175</pub-id>
                  <pub-id pub-id-type="pmid">23916895</pub-id>
                </element-citation>
              </ref>
              <ref id="B99-curroncol-29-00658">
                <label>99.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lomeli</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lepe</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gupta</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Bota</surname>
                      <given-names>D.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive Complications of Cancer and Cancer-Related Treatments—Novel Paradigms</article-title>
                  <source>Neurosci. Lett.</source>
                  <year>2021</year>
                  <volume>749</volume>
                  <fpage>135720</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.neulet.2021.135720</pub-id>
                  <pub-id pub-id-type="pmid">33582187</pub-id>
                </element-citation>
              </ref>
              <ref id="B100-curroncol-29-00658">
                <label>100.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Országhová</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Mego</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Chovanec</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-Term Cognitive Dysfunction in Cancer Survivors</article-title>
                  <source>Front. Mol. Biosci.</source>
                  <year>2021</year>
                  <volume>8</volume>
                  <fpage>770413</fpage>
                  <pub-id pub-id-type="doi">10.3389/fmolb.2021.770413</pub-id>
                  <pub-id pub-id-type="pmid">34970595</pub-id>
                </element-citation>
              </ref>
              <ref id="B101-curroncol-29-00658">
                <label>101.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zwielehner</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lassl</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Hippe</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Pointner</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Switzeny</surname>
                      <given-names>O.J.</given-names>
                    </name>
                    <name>
                      <surname>Remely</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kitzweger</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Ruckser</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Haslberger</surname>
                      <given-names>A.G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE Fingerprinting</article-title>
                  <source>PLoS ONE</source>
                  <year>2011</year>
                  <volume>6</volume>
                  <elocation-id>e28654</elocation-id>
                  <pub-id pub-id-type="pmid">22194876</pub-id>
                </element-citation>
              </ref>
              <ref id="B102-curroncol-29-00658">
                <label>102.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Montassier</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Batard</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Massart</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Gastinne</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Carton</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Caillon</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Le Fresne</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Caroff</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Hardouin</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Moreau</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>16S RRNA Gene Pyrosequencing Reveals Shift in Patient Faecal Microbiota during High-Dose Chemotherapy as Conditioning Regimen for Bone Marrow Transplantation</article-title>
                  <source>Microb. Ecol.</source>
                  <year>2014</year>
                  <volume>67</volume>
                  <fpage>690</fpage>
                  <lpage>699</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00248-013-0355-4</pub-id>
                  <pub-id pub-id-type="pmid">24402367</pub-id>
                </element-citation>
              </ref>
              <ref id="B103-curroncol-29-00658">
                <label>103.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rajagopala</surname>
                      <given-names>S.V.</given-names>
                    </name>
                    <name>
                      <surname>Yooseph</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Harkins</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Moncera</surname>
                      <given-names>K.J.</given-names>
                    </name>
                    <name>
                      <surname>Zabokrtsky</surname>
                      <given-names>K.B.</given-names>
                    </name>
                    <name>
                      <surname>Torralba</surname>
                      <given-names>M.G.</given-names>
                    </name>
                    <name>
                      <surname>Tovchigrechko</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Highlander</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Pieper</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Sender</surname>
                      <given-names>L.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gastrointestinal Microbial Populations Can Distinguish Pediatric and Adolescent Acute Lymphoblastic Leukemia (ALL) at the Time of Disease Diagnosis</article-title>
                  <source>BMC Genom.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <elocation-id>635</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/s12864-016-2965-y</pub-id>
                </element-citation>
              </ref>
              <ref id="B104-curroncol-29-00658">
                <label>104.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Urban</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Pyles</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Stewart</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Ajami</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Randolph</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Durham</surname>
                      <given-names>W.J.</given-names>
                    </name>
                    <name>
                      <surname>Danesi</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <name>
                      <surname>Dillon</surname>
                      <given-names>E.L.</given-names>
                    </name>
                    <name>
                      <surname>Summons</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>C.K.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Altered Fecal Microbiome Years after Traumatic Brain Injury</article-title>
                  <source>J. Neurotrauma</source>
                  <year>2020</year>
                  <volume>37</volume>
                  <fpage>1037</fpage>
                  <lpage>1051</lpage>
                  <pub-id pub-id-type="doi">10.1089/neu.2019.6688</pub-id>
                  <pub-id pub-id-type="pmid">31868094</pub-id>
                </element-citation>
              </ref>
              <ref id="B105-curroncol-29-00658">
                <label>105.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Urban</surname>
                      <given-names>R.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Treatable Syndrome in Patients with Traumatic Brain Injury</article-title>
                  <source>J. Neurotrauma</source>
                  <year>2020</year>
                  <volume>37</volume>
                  <fpage>1124</fpage>
                  <lpage>1125</lpage>
                  <pub-id pub-id-type="doi">10.1089/neu.2019.6689</pub-id>
                  <pub-id pub-id-type="pmid">31724478</pub-id>
                </element-citation>
              </ref>
              <ref id="B106-curroncol-29-00658">
                <label>106.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Callan</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Ladds</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Husain</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Pattinson</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Greenhalgh</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>“I Can’t Cope with Multiple Inputs”: A Qualitative Study of the Lived Experience of “brain Fog” after COVID-19</article-title>
                  <source>BMJ Open</source>
                  <year>2022</year>
                  <volume>12</volume>
                  <fpage>e056366</fpage>
                  <pub-id pub-id-type="doi">10.1136/bmjopen-2021-056366</pub-id>
                </element-citation>
              </ref>
              <ref id="B107-curroncol-29-00658">
                <label>107.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Mak</surname>
                      <given-names>J.W.Y.</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Yeoh</surname>
                      <given-names>Y.K.</given-names>
                    </name>
                    <name>
                      <surname>Lui</surname>
                      <given-names>G.C.-Y.</given-names>
                    </name>
                    <name>
                      <surname>Ng</surname>
                      <given-names>S.S.S.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>A.Y.L.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Hui</surname>
                      <given-names>D.S.-C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Gut Microbiota Dynamics in a Prospective Cohort of Patients with Post-Acute COVID-19 Syndrome</article-title>
                  <source>Gut</source>
                  <year>2022</year>
                  <volume>71</volume>
                  <fpage>544</fpage>
                  <lpage>552</lpage>
                  <pub-id pub-id-type="doi">10.1136/gutjnl-2021-325989</pub-id>
                  <pub-id pub-id-type="pmid">35082169</pub-id>
                </element-citation>
              </ref>
              <ref id="B108-curroncol-29-00658">
                <label>108.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cockshell</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Mathias</surname>
                      <given-names>J.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cognitive Functioning in Chronic Fatigue Syndrome: A Meta-Analysis</article-title>
                  <source>Psychol. Med.</source>
                  <year>2010</year>
                  <volume>40</volume>
                  <fpage>1253</fpage>
                  <lpage>1267</lpage>
                  <pub-id pub-id-type="doi">10.1017/S0033291709992054</pub-id>
                  <pub-id pub-id-type="pmid">20047703</pub-id>
                </element-citation>
              </ref>
              <ref id="B109-curroncol-29-00658">
                <label>109.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Giloteaux</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Goodrich</surname>
                      <given-names>J.K.</given-names>
                    </name>
                    <name>
                      <surname>Walters</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Levine</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Ley</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Hanson</surname>
                      <given-names>M.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Reduced Diversity and Altered Composition of the Gut Microbiome in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome</article-title>
                  <source>Microbiome</source>
                  <year>2016</year>
                  <volume>4</volume>
                  <fpage>30</fpage>
                  <pub-id pub-id-type="doi">10.1186/s40168-016-0171-4</pub-id>
                  <pub-id pub-id-type="pmid">27338587</pub-id>
                </element-citation>
              </ref>
              <ref id="B110-curroncol-29-00658">
                <label>110.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wasser</surname>
                      <given-names>C.I.</given-names>
                    </name>
                    <name>
                      <surname>Mercieca</surname>
                      <given-names>E.-C.</given-names>
                    </name>
                    <name>
                      <surname>Kong</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Hannan</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>McKeown</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Glikmann-Johnston</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Stout</surname>
                      <given-names>J.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Gut Dysbiosis in Huntington’s Disease: Associations among Gut Microbiota, Cognitive Performance and Clinical Outcomes</article-title>
                  <source>Brain Commun.</source>
                  <year>2020</year>
                  <volume>2</volume>
                  <fpage>fcaa110</fpage>
                  <pub-id pub-id-type="doi">10.1093/braincomms/fcaa110</pub-id>
                  <pub-id pub-id-type="pmid">33005892</pub-id>
                </element-citation>
              </ref>
              <ref id="B111-curroncol-29-00658">
                <label>111.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hughes</surname>
                      <given-names>H.K.</given-names>
                    </name>
                    <name>
                      <surname>Rose</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Ashwood</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Gut Microbiota and Dysbiosis in Autism Spectrum Disorders</article-title>
                  <source>Curr. Neurol. Neurosci. Rep.</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <fpage>81</fpage>
                  <pub-id pub-id-type="doi">10.1007/s11910-018-0887-6</pub-id>
                  <pub-id pub-id-type="pmid">30251184</pub-id>
                </element-citation>
              </ref>
              <ref id="B112-curroncol-29-00658">
                <label>112.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Neroni</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Evangelisti</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Radocchia</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Di Nardo</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Pantanella</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Villa</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Schippa</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Relationship between Sleep Disorders and Gut Dysbiosis: What Affects What?</article-title>
                  <source>Sleep Med.</source>
                  <year>2021</year>
                  <volume>87</volume>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.sleep.2021.08.003</pub-id>
                  <pub-id pub-id-type="pmid">34479058</pub-id>
                </element-citation>
              </ref>
              <ref id="B113-curroncol-29-00658">
                <label>113.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hajjar</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Mendoza</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Piha-Paul</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Hong</surname>
                      <given-names>D.S.</given-names>
                    </name>
                    <name>
                      <surname>Janku</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Karp</surname>
                      <given-names>D.D.</given-names>
                    </name>
                    <name>
                      <surname>Ballhausen</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Associations between the Gut Microbiome and Fatigue in Cancer Patients</article-title>
                  <source>Sci. Rep.</source>
                  <year>2021</year>
                  <volume>11</volume>
                  <fpage>5847</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-021-84783-9</pub-id>
                  <pub-id pub-id-type="pmid">33712647</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="curroncol-29-00658-f001">
              <label>Figure 1</label>
              <caption>
                <p>History of study participants from enrollment through post-study assessments.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g001" position="float"/>
            </fig>
            <fig position="float" id="curroncol-29-00658-f002">
              <label>Figure 2</label>
              <caption>
                <p>Correlations among baseline questionnaire scores and serum cytokine levels in cancer patients. Statistically significant correlations are denoted with an asterisk. Downward arrows indicate that lower scores are undesirable and indicate greater symptom severity; upward arrows indicate that higher scores are undesirable and indicate greater symptom severity. MFSI—Multidimensional Fatigue Symptom Inventory—Short Form, SF-36—RAND 36-Item Health Survey 1.0, POMS—Profile of Mood States—Short Form, BFI—Brief Fatigue Inventory, MDASI—MD Anderson Symptom Inventory, VAS—Visual Analog Scale.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g002" position="float"/>
            </fig>
            <fig position="float" id="curroncol-29-00658-f003">
              <label>Figure 3</label>
              <caption>
                <p>Percent change (average ± SD) in serum cytokine concentrations from baseline to post-treatment for cancer patients receiving testosterone (<italic toggle="yes">n</italic> = 7) or placebo <italic toggle="yes">(n</italic> = 11). There were no significant differences between groups after correcting for multiple testing. Abbreviations: GM-CSF—granulocyte-macrophage colony-stimulating factor, IFN-γ—interferon-gamma, IL—interleukin, tumor necrosis factor—TNF-α.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g003" position="float"/>
            </fig>
            <fig position="float" id="curroncol-29-00658-f004">
              <label>Figure 4</label>
              <caption>
                <p>Daily questionnaire scores averaged by week for cancer patients receiving testosterone or placebo. Average (±SD) weekly scores for (<bold>A</bold>) Brief Fatigue Inventory—BFI, (<bold>B</bold>) visual analog scale for fatigue—VAS Fatigue, (<bold>C</bold>) visual analog scale for nausea—VAS Nausea, (<bold>D</bold>) MD Anderson Symptom Inventory severity—MDASI Severity, and (<bold>E</bold>) MD Anderson Symptom Inventory interference—MDASI Interference. There were no significant differences between groups or in scores over time for either group. Higher scores on presented questionnaires are undesirable and indicate greater symptom severity.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g004" position="float"/>
            </fig>
            <fig position="float" id="curroncol-29-00658-f005">
              <label>Figure 5</label>
              <caption>
                <p>Multidimensional Fatigue Symptom Inventory—Short Form (MFSI) subscale and total scores at pre, mid, and post for cancer patients receiving testosterone or placebo. Average (±SD) scores for (<bold>A</bold>) General Fatigue, (<bold>B</bold>) Physical Fatigue, (<bold>C</bold>) Emotional Fatigue, (<bold>D</bold>) Mental Fatigue, and (<bold>E</bold>) Vigor subscales, as well as (<bold>F</bold>) Total score. Average (±SD) normative scores [<xref rid="B62-curroncol-29-00658" ref-type="bibr">62</xref>], as available, are displayed in gray sidebars to the right of each graph. There were no significant differences between groups or in scores over time for either group. Higher scores on presented questionnaires are undesirable and indicate greater symptom severity, with the exception of Vigor (<bold>E</bold>), for which lower scores are undesirable and indicate greater symptom severity.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g005" position="float"/>
            </fig>
            <fig position="float" id="curroncol-29-00658-f006">
              <label>Figure 6</label>
              <caption>
                <p>Profile of Mood States—Short Form (POMS) subscale and total scores at pre, mid, and post for cancer patients receiving testosterone or placebo. Average (±SD) scores for (<bold>A</bold>) Tension–Anxiety, (<bold>B</bold>) Depression, (<bold>C</bold>) Anger–Hostility, (<bold>D</bold>) Vigor, (<bold>E</bold>) Fatigue, and (<bold>F</bold>) Confusion subscales, as well as (<bold>G</bold>) Total Mood Disturbance score. Average (±SD) normative scores [<xref rid="B65-curroncol-29-00658" ref-type="bibr">65</xref>], as available, are displayed in gray sidebars to the right of each graph. There were no significant differences between groups or in scores over time for either group after adjusting for multiple testing. Higher scores on presented questionnaires are undesirable and indicate greater symptom severity, with the exception of Vigor (<bold>D</bold>), for which lower scores are undesirable and indicate greater symptom severity.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g006" position="float"/>
            </fig>
            <fig position="float" id="curroncol-29-00658-f007">
              <label>Figure 7</label>
              <caption>
                <p>RAND 36-Item Health Survey 1.0 (SF-36) scale scores at pre, mid, and post for cancer patients receiving testosterone or placebo. Average (±SD) scores for (<bold>A</bold>) Physical Functioning, (<bold>B</bold>) Energy/Fatigue, (<bold>C</bold>) Emotional Well Being, (<bold>D</bold>) Social Functioning, (<bold>E</bold>) Pain, and (<bold>F</bold>) General Health scales. Average (±SD) normative scores [<xref rid="B67-curroncol-29-00658" ref-type="bibr">67</xref>], as available, are displayed in gray sidebars to the right of each graph. There were no significant differences between groups or in scores over time for either group. Lower scores on presented questionnaires are undesirable and indicate greater symptom severity.</p>
              </caption>
              <graphic xlink:href="curroncol-29-00658-g007" position="float"/>
            </fig>
            <table-wrap position="float" id="curroncol-29-00658-t001">
              <object-id pub-id-type="pii">curroncol-29-00658-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Demographics of cervical or head and neck cancer patients receiving 7 weeks of adjunct testosterone or placebo.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Placebo</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Testosterone</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                  </tr>
                  <tr>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic toggle="yes">N</italic> = 21)</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic toggle="yes">N</italic> = 11)</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(<italic toggle="yes">N</italic> = 10)</th>
                    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">p</italic>
                    </th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Age (y)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Mean ± SD</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">51.9 ± 10.1</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">50.1 ± 11.8</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">53.9 ± 8</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.39</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Range</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">35–71</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">35–71</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">35–61</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Body Mass (initial, kg)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Mean ± SD</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">65.4 ± 22.6</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">69.4 ± 25.7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">60.9 ± 19.1</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.40</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Range</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">22.6–130.7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">44.4–130.7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">39–101</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">BMI (initial)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Mean ± SD</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">23 ± 6.8</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">23.9 ± 6.9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">22 ± 6.9</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.55</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Range</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">14.5–40.3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">16.3–40.3</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">14.5–37.6</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Days in study</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Mean ± SD</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">47.5 ± 8.8</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">47.8 ± 10</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">47 ± 7.7</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.81</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Sex—no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Male</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">10 (47.6)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7 (63.6)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3 (30)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.20</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Female</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">11 (52.4)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4 (36.3)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7 (70)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Race—no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Black</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4 (19.1)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (18.2)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.52</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Caucasian</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">15 (71.4)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7 (63.6)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8 (80)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Hispanic</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (9.5)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (18.2)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Tumor Stage—no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">IIB</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (9.5)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.71</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">III</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (4.8)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (9.1)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">IIIB</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5 (23.8)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3 (27.3)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">IV</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (4.8)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (9.1)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0 (0)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">IVA</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">9 (42.9)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4 (36.4)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5 (50)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">IVB</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">3 (14.3)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">2 (18.2)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1 (10)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Cancer Type—no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Cervical</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8 (38.1)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4 (36.4)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4 (40)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">1</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Head/neck</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">13 (61.9)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7 (63.6)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6 (60)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Received Treatment—no. (%)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">Chemotherapy</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">16 (76.2)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7 (63.6)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8 (80)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.64</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Radiation</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (90.5)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (90.9)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 (90)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="curroncol-29-00658-t002">
              <object-id pub-id-type="pii">curroncol-29-00658-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Baseline MFSI, SF-36, and POMS scores (mean ± SD) for cervical or head and neck cancer patients compared to normative data. Questionnaire scores/subscales that were significantly different after correction for multiple testing are indicated with an asterisk. Normative data for MFSI, SF-36, and POMS questionnaires from Cordero et al., 2012, Nyenhuis et al., 1999, and Ware et al., 1993, respectively. MFSI—Multidimensional Fatigue Symptom Inventory—Short Form, SF-36—RAND 36-Item Health Survey 1.0, POMS—Profile of Mood States—Short Form.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer Patients (n)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Normative Data (n)</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
                      <italic toggle="yes">p</italic>
                    </th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> (adj)</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MFSI General</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">8.5 ± 6.4 (21)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.3 ± 5.9 (176)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.413</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.966</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MFSI Physical</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.0 ± 4.9 (21)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.0 ± 4.4 (176)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.390</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.966</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MFSI Emotional</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.9 ± 6.0 (21)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.0 ± 4.6 (176)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.009</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.124</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MFSI Mental</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.2 ± 4.8 (21)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">4.2 ± 4.1 (176)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.384</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.966</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">MFSI Vigor</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">9.7 ± 5.9 (21)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">13.8 ± 5.6 (176)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.006</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.101</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SF-36 Physical Functioning *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">55.5 ± 28.6 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">84.2 ± 23.3 (2474)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>&lt;0.001</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.006</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SF-36 Limitations Physical *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">25.0 ± 36.3 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">81.0 ± 34.0 (2474)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>&lt;0.001</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>&lt;0.001</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SF-36 Limitations Emotional</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">56.1 ± 49.8 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">81.3 ± 33.0 (2474)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.041</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.343</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SF-36 Energy-Fatigue</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">46.6 ± 22.7 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">60.9 ± 21.0 (2474)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.014</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.152</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SF-36 Emotional Well Being</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">66.5 ± 19.3 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">74.7 ± 18.1 (2474)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.080</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.467</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">SF-36 Social Functioning *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">56.6 ± 32.4 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">83.3 ± 22.7 (2474)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.002</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.031</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">POMS Tension-Anxiety</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">11.0 ± 7.7 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.0 ± 5.5 (432)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>0.037</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.391</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">POMS Depression</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">11.3 ± 12.8 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.1 ± 8.4 (432)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.162</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.829</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">POMS Anger–Hostility</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.3 ± 9.2 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">6.6 ± 6.7 (432)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.740</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.966</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">POMS Vigor *</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">11.9 ± 6.7 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">20.2 ± 6.2 (432)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>&lt;0.001</bold>
                    </td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">
                      <bold>&lt;0.001</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">POMS Fatigue</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">9.3 ± 7.6 (20)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.3 ± 5.7 (432)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.259</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.933</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" rowspan="1" colspan="1">POMS Confusion</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">7.6 ± 5.5 (19)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">5.2 ± 4.1 (432)</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.076</td>
                    <td align="center" valign="middle" rowspan="1" colspan="1">0.579</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">POMS Total Mood Disturbance</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.0 ± 41.2 (19)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12.7 ± 29.6 (432)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
                      <bold>0.047</bold>
                    </td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.440</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
